{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:02:32Z","timestamp":1793804552035,"version":"4.6.1"},"reference-count":1617,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jacc.2023.08.017","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T13:57:42Z","timestamp":1701352662000},"page":"109-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":950,"title":["2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation"],"prefix":"10.1016","volume":"83","author":[{"given":"Jos\u00e9 A.","family":"Joglar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia L.","family":"Armbruster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emelia J.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Y.","family":"Chyou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond M.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Deswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee L.","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary D.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Gopinathannair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Gorenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hlatky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinwe","family":"Ibeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Indik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen T.","family":"Linta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen K.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco V.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Streur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Times","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Van Wagoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason G.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Beavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Jared","family":"Bunch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen Bova","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin Yee","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Dorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward P.","family":"Gerstenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Dwyer","family":"Kaluzna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Masha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Nault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Noseworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara N.","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos E.","family":"Tzeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle Santos","family":"Volgman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily P.","family":"Zeitler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2023.08.017_bib1","series-title":"Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"10.1016\/j.jacc.2023.08.017_bib2","series-title":"Finding What Works in Healthcare: Standards for Systematic Reviews","year":"2011"},{"key":"10.1016\/j.jacc.2023.08.017_bib3","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib4","series-title":"Methodology Manual and Policies From the ACCF\/AHA Task Force on Practice Guidelines","year":"2010"},{"key":"10.1016\/j.jacc.2023.08.017_bib5","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.jacc.2015.09.001","article-title":"Further evolution of the ACC\/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"67","author":"Halperin","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib6","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2014.07.012","volume":"64","author":"Arnett","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib7","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2019.02.012","article-title":"Recent innovations, modifications, and evolution of ACC\/AHA clinical practice guidelines: an update for our constituencies: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Levine","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib11","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib12","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jacc.2018.08.1029","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib13","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib14","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib15","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib16","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jacc.2021.07.053","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"78","author":"Gulati","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib17","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib18","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2023.08.017_bib19","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/j.hrthm.2023.05.017","article-title":"2023 HRS expert consensus statement on the management of arrhythmias during pregnancy","volume":"20","author":"Joglar","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib22","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics\u20142023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/clc.23983","article-title":"Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States","volume":"46","author":"Turakhia","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.hroo.2022.07.010","article-title":"Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation","volume":"3","author":"Deshmukh","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2023.08.017_bib26","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2020.0734","article-title":"US health care spending by payer and health condition, 1996-2016","volume":"323","author":"Dieleman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib27","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjqcco\/qcaa061","article-title":"Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the Global Burden of Disease Study 2017","volume":"7","author":"Dai","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib29","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006350","article-title":"Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (Atherosclerosis Risk in Communities)","volume":"11","author":"Mou","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/CIRCULATIONAHA.117.031431","article-title":"Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation","volume":"137","author":"Weng","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib32","doi-asserted-by":"crossref","first-page":"k1453","DOI":"10.1136\/bmj.k1453","article-title":"Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study","volume":"361","author":"Staerk","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chest.2017.10.001","article-title":"Lifetime risks, projected numbers, and adverse outcomes in Asian patients with atrial fibrillation: a report from the Taiwan Nationwide AF Cohort Study","volume":"153","author":"Chao","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib34","doi-asserted-by":"crossref","first-page":"h7013","DOI":"10.1136\/bmj.h7013","article-title":"Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies","volume":"532","author":"Emdin","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib35","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib36","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s11606-021-06954-8","article-title":"Atrial fibrillation is associated with cognitive impairment, all-cause dementia, vascular dementia, and Alzheimer's disease: a systematic review and meta-analysis","volume":"36","author":"Papanastasiou","year":"2021","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/2047487317715769","article-title":"Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: a systematic review and meta-analysis","volume":"24","author":"Ruddox","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10840-017-0308-9","article-title":"Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis","volume":"51","author":"Rattanawong","year":"2018","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/eurheartj\/eht483","article-title":"Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke","volume":"35","author":"Piccini","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10654-020-00618-3","article-title":"Environmental factors, serum biomarkers and risk of atrial fibrillation: an exposure-wide umbrella review of meta-analyses","volume":"35","author":"Belbasis","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib41","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib42","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1160\/TH16-11-0825","article-title":"Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants","volume":"117","author":"Allan","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib43","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/CIRCULATIONAHA.121.056456","article-title":"Epigenetic age and the risk of incident atrial fibrillation","volume":"144","author":"Roberts","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib44","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib45","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/2047487318780435","article-title":"Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Aune","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12920-021-00915-0","article-title":"Genetically determined tobacco and alcohol use and risk of atrial fibrillation","volume":"14","author":"Lu","year":"2021","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jacc.2023.08.017_bib47","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/jce.13023","article-title":"Differential association of exercise intensity with risk of atrial fibrillation in men and women: evidence from a meta-analysis","volume":"27","author":"Mohanty","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.hrthm.2020.12.017","article-title":"Self-reported physical activity and atrial fibrillation risk: a systematic review and meta-analysis","volume":"18","author":"Mishima","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib49","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bjsports-2021-103994","article-title":"Risk of atrial fibrillation in athletes: a systematic review and meta-analysis","volume":"55","author":"Newman","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2006.03.034","article-title":"Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation","volume":"116","author":"Hegbom","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib51","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.115.018220","article-title":"Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial","volume":"133","author":"Malmo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib52","first-page":"455","article-title":"An exercise and physical activity program in patients with atrial fibrillation: the ACTIVE-AF randomized controlled trial","volume":"9","author":"Elliott","year":"2023","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib53","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/HCR.0000000000000665","article-title":"Effects of supervised exercise training on atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"42","author":"Oesterle","year":"2022","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2023.08.017_bib55","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ahj.2011.09.013","article-title":"A\u00a0randomized study of the effects of exercise training on patients with atrial fibrillation","volume":"162","author":"Osbak","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib56","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.7326\/M21-0228","article-title":"Acute consumption of alcohol and discrete atrial fibrillation events","volume":"174","author":"Marcus","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib57","doi-asserted-by":"crossref","first-page":"i2714","DOI":"10.1136\/bmj.i2714","article-title":"Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws","volume":"353","author":"Dukes","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib58","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2021.5010","article-title":"Individualized studies of triggers of paroxysmal atrial fibrillation: the I-STOP-AFib randomized clinical trial","volume":"7","author":"Marcus","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib60","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib61","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib62","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib63","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib64","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2014.03.048","article-title":"Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis","volume":"64","author":"Larsson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib65","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0140-6736(14)61774-8","article-title":"50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study","volume":"386","author":"Schnabel","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib66","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007598","article-title":"Outcomes of atrial fibrillation ablation in morbidly obese patients following bariatric surgery compared with a nonobese cohort","volume":"12","author":"Donnellan","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib67","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/europace\/euz183","article-title":"Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation","volume":"21","author":"Donnellan","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib68","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007626","article-title":"Impact of bariatric surgery on atrial fibrillation type","volume":"13","author":"Donnellan","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib69","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/jce.13394","article-title":"Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation","volume":"29","author":"Mohanty","year":"2018","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib70","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10654-017-0232-4","article-title":"Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies","volume":"32","author":"Aune","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib71","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.7150\/ijms.72334","article-title":"The risk of atrial fibrillation increases with earlier onset of obesity: a Mendelian randomization study","volume":"19","author":"Zhou","year":"2022","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jacc.2023.08.017_bib72","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/ije\/dyac041","article-title":"A\u00a0phenome-wide bidirectional Mendelian randomization analysis of atrial fibrillation","volume":"51","author":"Wang","year":"2022","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib73","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib75","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCULATIONAHA.116.026230","article-title":"Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])","volume":"135","author":"Parkash","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib76","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.08.017_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib78","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/genes13071226","article-title":"Unravelling the distinct effects of systolic and diastolic blood pressure using Mendelian randomisation","volume":"13","author":"Le","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jacc.2023.08.017_bib79","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/HYPERTENSIONAHA.120.16191","article-title":"Genetically predicted blood pressure and risk of atrial fibrillation","volume":"77","author":"Hyman","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.08.017_bib80","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1536\/ihj.18-470","article-title":"Resting heart rate and the risk of atrial fibrillation","volume":"60","author":"Liu","year":"2019","journal-title":"Int Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268768","article-title":"Resting heart rate and incident atrial fibrillation: a stratified Mendelian randomization in the AFGen consortium","volume":"17","author":"Siland","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib82","first-page":"897","article-title":"Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation","volume":"5","author":"Donnellan","year":"2019","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib83","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","article-title":"Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","volume":"32","author":"Aune","year":"2018","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.jacc.2023.08.017_bib84","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98058-w","article-title":"Mendelian randomization study on atrial fibrillation and cardiovascular disease subtypes","volume":"11","author":"Kwok","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib86","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib87","article-title":"Genetically predicted atrial fibrillation and valvular heart disease: a two-sample Mendelian randomization study","volume":"9","author":"Gao","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib88","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","article-title":"A\u00a0multicenter risk index for atrial fibrillation after cardiac surgery","volume":"291","author":"Mathew","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib89","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.athoracsur.2019.07.056","article-title":"Preoperative \u03b2-blockers as a coronary surgery quality metric: the lack of evidence of efficacy","volume":"109","author":"Filardo","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib90","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib91","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2017.12.029","article-title":"Amiodarone protocol provides cost-effective reduction in postoperative atrial fibrillation","volume":"105","author":"Mehaffey","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib92","doi-asserted-by":"crossref","first-page":"152r","DOI":"10.1016\/S0002-9149(99)00716-X","article-title":"Intravenous antiarrhythmic regimens with focus on amiodarone for prophylaxis of atrial fibrillation after open heart surgery","volume":"84","author":"Guarnieri","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib93","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.294.24.3093","article-title":"Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial","volume":"294","author":"Mitchell","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib94","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0140-6736(21)02490-9","article-title":"Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial","volume":"398","author":"Gaudino","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib95","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.athoracsur.2020.05.104","article-title":"Postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis","volume":"111","author":"Eikelboom","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib96","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.athoracsur.2020.10.055","article-title":"Postoperative atrial fibrillation after cardiac surgery: a meta-analysis","volume":"112","author":"Woldendorp","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155581","article-title":"Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"11","author":"Shang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2022.03.004","article-title":"Disentangling the association between kidney function and atrial fibrillation: a bidirectional Mendelian randomization study","volume":"355","author":"Geurts","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib99","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/eurheartj\/ehab291","article-title":"Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study","volume":"42","author":"Park","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib100","article-title":"Association between obstructive sleep apnea (OSA) and atrial fibrillation (AF): a dose-response meta-analysis","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2023.08.017_bib101","article-title":"Effects of continuous positive airway pressure treatment in obstructive sleep apnea patients with atrial fibrillation: a meta-analysis","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2023.08.017_bib102","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10840-020-00738-6","article-title":"CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis","volume":"58","author":"Yang","year":"2020","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jebm.12313","article-title":"Effect of obstructive sleep apnea and its treatment of atrial fibrillation recurrence after radiofrequency catheter ablation: a meta-analysis","volume":"11","author":"Congrete","year":"2018","journal-title":"J\u00a0Evid Based Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib104","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.sleep.2018.02.013","article-title":"Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a meta-analysis","volume":"46","author":"Deng","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib105","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.amjcard.2015.08.046","article-title":"Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea","volume":"116","author":"Qureshi","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib106","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11325-014-1102-x","article-title":"Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations-a long-term prospective, cross-sectional cohort study","volume":"19","author":"Szymanski","year":"2015","journal-title":"Sleep Breath"},{"key":"10.1016\/j.jacc.2023.08.017_bib107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2018.11.100","article-title":"The impact of continuous positive airway pressure treatment on the recurrence of atrial fibrillation post cardioversion: a randomized controlled trial","volume":"278","author":"Caples","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib108","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.202011-4133OC","article-title":"Effect of continuous positive airway pressure on arrhythmia in atrial fibrillation and sleep apnea: a randomized controlled trial","volume":"204","author":"Traaen","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib109","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.hrthm.2022.06.016","article-title":"Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: a randomized controlled trial","volume":"19","author":"Hunt","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12920-022-01180-5","article-title":"Obstructive sleep apnea and atrial fibrillation: insights from a bidirectional Mendelian randomization study","volume":"15","author":"Chen","year":"2022","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jacc.2023.08.017_bib111","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.eprac.2022.05.008","article-title":"Effects of thyroid dysfunction and the thyroid-stimulating hormone levels on the risk of atrial fibrillation: a systematic review and dose-response meta-analysis from cohort studies","volume":"28","author":"Huang","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jacc.2023.08.017_bib112","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2018.4635","article-title":"Assessment of the relationship between genetic determinants of thyroid function and atrial fibrillation: a Mendelian randomization study","volume":"4","author":"Ellervik","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib113","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1001\/jama.2011.1615","article-title":"Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis","volume":"306","author":"Walkey","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib114","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ahj.2013.03.020","article-title":"Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors","volume":"165","author":"Walkey","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/CCM.0000000000003560","article-title":"Risk factors for new-onset atrial fibrillation in patients with sepsis: a systematic review and meta-analysis","volume":"47","author":"Bosch","year":"2019","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib116","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/heartjnl-2015-308956","article-title":"Prolonged PR interval, first-degree heart block and adverse cardiovascular outcomes: a systematic review and meta-analysis","volume":"102","author":"Kwok","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib117","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1038\/s41467-020-15706-x","article-title":"Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction","volume":"11","author":"Ntalla","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacc.2023.08.017_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.639993","article-title":"The association between left ventricular hypertrophy and the occurrence and prognosis of atrial fibrillation: a meta-analysis","volume":"8","author":"Xiang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib119","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/europace\/euu175","article-title":"B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies","volume":"16","author":"Sinner","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib120","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/europace\/euaa158","article-title":"Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort","volume":"22","author":"Geelhoed","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib121","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2013.08.078","article-title":"Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis","volume":"169","author":"Wu","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib122","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jacc.2022.02.018","article-title":"Elevated lipoprotein(a) and risk of atrial fibrillation: an observational and Mendelian randomization study","volume":"79","author":"Mohammadi-Shemirani","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib123","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.89.2.724","article-title":"Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study","volume":"89","author":"Vaziri","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib124","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jcmg.2017.12.016","article-title":"Relationship between left atrial functional measures and incident atrial fibrillation in the general population: the Copenhagen City Heart Study","volume":"12","author":"Olsen","year":"2019","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.08.017_bib125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-2005-865873","article-title":"Left atrial size reduction improves the sinus rhythm conversion rate after radiofrequency ablation for continuous atrial fibrillation in patients undergoing concomitant cardiac surgery","volume":"54","author":"Scherer","year":"2006","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib126","first-page":"469","article-title":"Impact of left atrial size reduction on chronic atrial fibrillation in mitral valve surgery","volume":"12","author":"Scherer","year":"2003","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib127","first-page":"126","article-title":"Impact of left atrial size reduction and endocardial radiofrequency ablation on continuous atrial fibrillation in patients undergoing concomitant cardiac surgery: three-year results","volume":"16","author":"Scherer","year":"2007","journal-title":"J\u00a0Heart Valve Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib128","first-page":"797","article-title":"Early and long-term outcomes and quality of life after concomitant mitral valve surgery, left atrial size reduction, and radiofrequency surgical ablation of atrial fibrillation","volume":"16","author":"Joshibayev","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib129","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1038\/s41598-021-87859-8","article-title":"Atrial fibrillation and left atrial size and function: a Mendelian randomization study","volume":"11","author":"van de Vegte","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib130","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006350","article-title":"Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (Atherosclerosis Risk in Communities)","volume":"11","author":"Mou","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib131","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jech-2019-212720","article-title":"Socioeconomic position and risk of atrial fibrillation: a nationwide Danish cohort study","volume":"74","author":"Lunde","year":"2020","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.jacc.2023.08.017_bib132","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5334\/gh.1107","article-title":"Education and atrial fibrillation: Mendelian randomization study","volume":"17","author":"Liu","year":"2022","journal-title":"Glob Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib133","first-page":"kwab046","article-title":"Life course socioeconomic status and risk of hospitalization for heart failure or atrial fibrillation in the Moli-Sani study cohort","volume":"Feb 24","author":"Bonaccio","year":"2021","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib134","article-title":"Atrial fibrillation epidemiology, disparity and healthcare contacts: a population-wide study of 5.6 million individuals","volume":"7","author":"Chung","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jacc.2023.08.017_bib135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14779072.2018.1533118","article-title":"Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review","volume":"16","author":"Lunde","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib136","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.2497","article-title":"Association between family history and early-onset atrial fibrillation across racial and ethnic groups","volume":"1","author":"Alzahrani","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib137","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/eurheartj\/ehi727","article-title":"Familial aggregation of atrial fibrillation in Iceland","volume":"27","author":"Arnar","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib138","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2010.1690","article-title":"Association between familial atrial fibrillation and risk of new-onset atrial fibrillation","volume":"304","author":"Lubitz","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib139","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41588-018-0133-9","article-title":"Multi-ethnic genome-wide association study for atrial fibrillation","volume":"50","author":"Roselli","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2023.08.017_bib140","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","article-title":"Biobank-driven genomic discovery yields new insight into atrial fibrillation biology","volume":"50","author":"Nielsen","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2023.08.017_bib141","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1053\/euhj.2001.2658","volume":"22","author":"Saoudi","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib142","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehz467","article-title":"2019 ESC guidelines for the management of patients with supraventricular tachycardia","volume":"41","author":"Brugada","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib143","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.CIR.0000027683.00417.9A","article-title":"Contemporary management of atrial flutter","volume":"106","author":"Wellens","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib144","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib145","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0008-6363(02)00258-4","article-title":"Electrical, contractile and structural remodeling during atrial fibrillation","volume":"54","author":"Allessie","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib146","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib147","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fphys.2020.00237","article-title":"Arrhythmogenic Interaction Between Sympathetic Tone and Mechanical Stretch in Rat Pulmonary Vein Myocardium","volume":"11","author":"Egorov","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib148","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.RES.85.5.428","article-title":"Atrial L-type Ca2+ currents and human atrial fibrillation","volume":"85","author":"Van Wagoner","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib149","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/01.RES.80.6.772","article-title":"Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation","volume":"80","author":"Van Wagoner","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib150","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCEP.110.954636","article-title":"Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation","volume":"3","author":"Voigt","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib151","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.yjmcc.2014.08.021","article-title":"Connexin40 abnormalities and atrial fibrillation in the human heart","volume":"76","author":"Gemel","year":"2014","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib152","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCEP.110.959726","article-title":"A\u00a0common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation","volume":"4","author":"Wirka","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib153","article-title":"Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression","volume":"8","author":"Lazzerini","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib154","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/cvr\/cvs366","article-title":"c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias","volume":"97","author":"Yan","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib155","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jacc.2014.05.077","article-title":"Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model","volume":"64","author":"Iwasaki","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib156","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCRESAHA.117.310083","article-title":"Calcium Signaling and Cardiac Arrhythmias","volume":"120","author":"Landstrom","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib157","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.hrthm.2019.10.016","article-title":"Calmodulin kinase II regulates atrial myocyte late sodium current, calcium handling, and atrial arrhythmia","volume":"17","author":"Greer-Short","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib158","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1161\/CIRCULATIONAHA.111.067306","article-title":"Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation","volume":"125","author":"Voigt","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib159","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00424-021-02515-4","article-title":"The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation","volume":"473","author":"Wang","year":"2021","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jacc.2023.08.017_bib160","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Haissaguerre","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib161","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-159-11-201312030-00004","article-title":"Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study","volume":"159","author":"Dewland","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib162","article-title":"Associations of left atrial function and structure with supraventricular ectopy: the Multi-Ethnic Study of Atherosclerosis","volume":"10","author":"Heckbert","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib163","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.011623","article-title":"Premature atrial contraction location and atrial fibrillation inducibility","volume":"16","author":"Howell","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib164","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCEP.110.954636","article-title":"Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation","volume":"3","author":"Voigt","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib165","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1540-8167.2008.01403.x","article-title":"Frequency analysis of atrial electrograms identifies conduction pathways from the left to the right atrium during atrial fibrillation-studies in two canine models","volume":"20","author":"Ryu","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib166","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.hrthm.2016.05.028","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"14","author":"Goette","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib167","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib168","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.jacc.2004.07.055","article-title":"Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability","volume":"44","author":"Deroubaix","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib169","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.113.003313","article-title":"Oxidized Ca(2+)\/calmodulin-dependent protein kinase II triggers atrial fibrillation","volume":"128","author":"Purohit","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib170","doi-asserted-by":"crossref","DOI":"10.1172\/JCI95747","article-title":"Oxidized CaMKII and O-GlcNAcylation cause increased atrial fibrillation in diabetic mice by distinct mechanisms","volume":"131","author":"Mesubi","year":"2021","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jacc.2023.08.017_bib171","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/CIRCRESAHA.117.312536","article-title":"Stress signaling JNK2 crosstalk with CaMKII underlies enhanced atrial arrhythmogenesis","volume":"122","author":"Yan","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib172","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCRESAHA.120.318409","article-title":"JNK2, a newly-identified SERCA2 enhancer, augments an arrhythmic [Ca(2+)]SR leak-load relationship","volume":"128","author":"Yan","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib173","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib174","first-page":"602","article-title":"Highly reactive isolevuglandins promote atrial fibrillation caused by hypertension","volume":"5","author":"Prinsen","year":"2020","journal-title":"J Am Coll Cardiol Basic Trans Science"},{"key":"10.1016\/j.jacc.2023.08.017_bib175","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/cvr\/cvab124","article-title":"Oxidative stress: a bystander or a causal contributor to atrial remodelling and fibrillation?","volume":"117","author":"Dobrev","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib176","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib177","doi-asserted-by":"crossref","first-page":"N136","DOI":"10.1097\/00003246-200010001-00005","article-title":"Cardiac surgery: postoperative arrhythmias","volume":"28","author":"Chung","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib178","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib179","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib180","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","article-title":"Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib181","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2018.11.091","article-title":"Role of autonomic nervous system in atrial fibrillation","volume":"287","author":"Linz","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib182","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.4022\/jafib.2400","article-title":"The \"road\" to atrial fibrillation: the role of the cardiac autonomic nervous system","volume":"13","author":"Malik","year":"2020","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.jacc.2023.08.017_bib183","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/eurheartj\/ehv375","article-title":"Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications","volume":"37","author":"Lau","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib184","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1152\/physrev.00031.2009","article-title":"Pathophysiological mechanisms of atrial fibrillation: a translational appraisal","volume":"91","author":"Schotten","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib185","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","article-title":"Atrial fibrillation pathophysiology: implications for management","volume":"124","author":"Iwasaki","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib186","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.CIR.101.10.1185","article-title":"Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation","volume":"101","author":"Jayachandran","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib187","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.CIR.103.1.22","article-title":"Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing","volume":"103","author":"Chang","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib188","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/pace.12450","article-title":"Atrial fibrillation increases sympathetic and parasympathetic neurons in the intrinsic cardiac nervous system","volume":"37","author":"Yu","year":"2014","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib189","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130532","article-title":"Region-specific parasympathetic nerve remodeling in the left atrium contributes to creation of a vulnerable substrate for atrial fibrillation","volume":"4","author":"Gussak","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacc.2023.08.017_bib190","first-page":"152","article-title":"Autonomic afferent dysregulation in atrial fibrillation","volume":"8","author":"Malik","year":"2022","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib191","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10840-019-00508-z","article-title":"Clinical evidence of autonomic dysfunction due to atrial fibrillation: implications for rhythm control strategy","volume":"54","author":"Malik","year":"2019","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib192","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/01.CIR.0000064900.76674.CC","article-title":"Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects","volume":"107","author":"Wasmund","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib193","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-8703(89)90075-6","article-title":"Neurohumoral and hemodynamic effects of lower body negative pressure in patients with congestive heart failure","volume":"118","author":"Mohanty","year":"1989","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib194","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/europace\/euz339","article-title":"Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study","volume":"22","author":"De With","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib195","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2010.1690","article-title":"Association between familial atrial fibrillation and risk of new-onset atrial fibrillation","volume":"304","author":"Lubitz","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib196","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM199703273361302","article-title":"Identification of a genetic locus for familial atrial fibrillation","volume":"336","author":"Brugada","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib197","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1077771","article-title":"KCNQ1 gain-of-function mutation in familial atrial fibrillation","volume":"299","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jacc.2023.08.017_bib198","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.117.001838","article-title":"Heritability of atrial fibrillation","volume":"10","author":"Weng","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2023.08.017_bib199","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41588-018-0133-9","article-title":"Multi-ethnic genome-wide association study for atrial fibrillation","volume":"50","author":"Roselli","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2023.08.017_bib200","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/ng.3842","article-title":"Identification of six new genetic loci associated with atrial fibrillation in the Japanese population","volume":"49","author":"Low","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2023.08.017_bib201","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/eurheartj\/ehx213","article-title":"Korean atrial fibrillation network genome-wide association study for early-onset atrial fibrillation identifies novel susceptibility loci","volume":"38","author":"Lee","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCRESAHA.119.315686","article-title":"Monogenic and polygenic contributions to atrial fibrillation risk: results from a national biobank","volume":"126","author":"Choi","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib203","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jamacardio.2021.3370","article-title":"Early-onset atrial fibrillation and the prevalence of rare variants in cardiomyopathy and arrhythmia genes","volume":"6","author":"Yoneda","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib204","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2021.0994","article-title":"Association of rare genetic variants and early-onset atrial fibrillation in ethnic minority individuals","volume":"6","author":"Chalazan","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib206","doi-asserted-by":"crossref","first-page":"n991","DOI":"10.1136\/bmj.n991","article-title":"Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study","volume":"373","author":"Kim","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib207","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.cjco.2021.09.004","article-title":"Racial and ethnic differences in the management of atrial fibrillation","volume":"3","author":"Tamirisa","year":"2021","journal-title":"CJC Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib208","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14779072.2018.1533118","article-title":"Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review","volume":"16","author":"Lunde","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib209","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ehjqcco\/qcz053","article-title":"Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter","volume":"7","author":"Hagengaard","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib210","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1161\/CIR.0000000000000753","article-title":"Call to action: rural health: a presidential advisory from the American Heart Association and American Stroke Association","volume":"141","author":"Harrington","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib211","article-title":"Sex differences in the use of oral anticoagulants for atrial fibrillation: a report from the National Cardiovascular Data Registry (NCDR\u00ae) PINNACLE registry","volume":"6","author":"Thompson","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib212","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.hrthm.2015.03.031","article-title":"Race- and sex-related differences in care for patients newly diagnosed with atrial fibrillation","volume":"12","author":"Bhave","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib213","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.hrthm.2015.06.029","article-title":"Temporal trends and sex differences in pulmonary vein isolation for patients with atrial fibrillation","volume":"12","author":"Avgil Tsadok","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib214","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.amjcard.2016.01.040","article-title":"Gender, race, and health insurance status in patients undergoing catheter ablation for atrial fibrillation","volume":"117","author":"Patel","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib215","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.hrthm.2018.05.019","article-title":"Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: a systematic review","volume":"15","author":"Ugowe","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib216","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/jamacardio.2022.4091","article-title":"Transforming atrial fibrillation research to integrate social determinants of health: a National Heart, Lung, and Blood Institute Workshop Report","volume":"8","author":"Benjamin","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib217","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.amepre.2017.05.011","article-title":"A\u00a0systematic review of interventions on patients' social and economic needs","volume":"53","author":"Gottlieb","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib218","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1161\/CIR.0000000000000767","article-title":"Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association","volume":"141","author":"White-Williams","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib219","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/M20-0730","article-title":"Developing primary care-based recommendations for social determinants of health: methods of the U.S. Preventive Services Task Force","volume":"173","author":"Davidson","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib220","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.2021.12833","article-title":"Incorporation of social risk in US Preventive Services Task Force recommendations and identification of key challenges for primary care","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib221","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1111\/jce.14838","article-title":"Women and atrial fibrillation","volume":"32","author":"Volgman","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib222","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.120.051558","article-title":"Association between sex and treatment outcomes of atrial fibrillation ablation versus drug therapy: results from the CABANA trial","volume":"143","author":"Russo","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib223","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1111\/jce.14758","article-title":"Sex-based differences in procedural complications associated with atrial fibrillation catheter ablation: a systematic review and meta-analysis","volume":"31","author":"Campbell","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib224","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jacc.2021.04.092","article-title":"Ablation versus drug therapy for atrial fibrillation in racial and ethnic minorities","volume":"78","author":"Thomas","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib226","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCULATIONAHA.122.058949","article-title":"Association of neighborhood-level material deprivation with atrial fibrillation care in a single-payer health care system: a population-based cohort study","volume":"146","author":"Abdel-Qadir","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib227","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.961","article-title":"Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: a Finnish nationwide cohort study","volume":"10","author":"Teppo","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jacc.2023.08.017_bib228","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.amjcard.2018.04.022","article-title":"Influence of sociodemographic factors and provider specialty on anticoagulation prescription fill patterns and outcomes in atrial fibrillation","volume":"122","author":"O'Neal","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib229","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0247","article-title":"Racial\/ethnic and socioeconomic disparities in management of incident paroxysmal atrial fibrillation","volume":"4","author":"Eberly","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100201","article-title":"Association of income and educational attainment in hospitalization events in atrial fibrillation","volume":"7","author":"Tertulien","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib231","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1136\/heartjnl-2019-316065","article-title":"Association of household income and adverse outcomes in patients with atrial fibrillation","volume":"106","author":"LaRosa","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib232","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjcard.2018.11.045","article-title":"Comparison of baseline characteristics and in-hospital outcomes in medicaid versus private insurance hospitalizations for atrial fibrillation","volume":"123","author":"Doshi","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib233","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamainternmed.2020.2908","article-title":"Assessment of shared decision-making for stroke prevention in patients with atrial fibrillation: a randomized clinical trial","volume":"180","author":"Kunneman","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib234","article-title":"A\u00a0randomized clinical trial to evaluate an atrial fibrillation stroke prevention shared decision-making pathway","volume":"12","author":"Wang","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib235","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/0272989X211005655","article-title":"Shared decision making tools for people facing stroke prevention strategies in atrial fibrillation: a systematic review and environmental scan","volume":"41","author":"Torres Roldan","year":"2021","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jacc.2023.08.017_bib236","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/eurjcn\/zvab085","article-title":"Decision aids for shared decision-making and appropriate anticoagulation therapy in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"21","author":"Song","year":"2022","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.jacc.2023.08.017_bib237","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.007958","article-title":"Shared decision making in cardiac electrophysiology procedures and arrhythmia management","volume":"14","author":"Chung","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib238","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1177\/0272989X211020317","article-title":"A\u00a0systematic review and meta-analysis of patient decision aids for socially disadvantaged populations: update from the International Patient Decision Aid Standards (IDPAS)","volume":"41","author":"Yen","year":"2021","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jacc.2023.08.017_bib239","article-title":"Effect of shared decision-making for stroke prevention on treatment adherence and safety outcomes in patients with atrial fibrillation: a randomized clinical trial","volume":"11","author":"Noseworthy","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib240","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15420\/ecr.2017:2:2","article-title":"Health literacy and atrial fibrillation: relevance and future directions for patient-centred care","volume":"12","author":"Aronis","year":"2017","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib241","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ahj.2022.02.010","article-title":"Randomized evaluation of decision support interventions for atrial fibrillation: rationale and design of the RED-AF study","volume":"248","author":"Jones","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib242","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib243","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamainternmed.2020.2908","article-title":"Assessment of shared decision-making for stroke prevention in patients with atrial fibrillation: a randomized clinical trial","volume":"180","author":"Kunneman","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib244","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/europace\/euaa005","article-title":"Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis","volume":"22","author":"Himmelreich","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib245","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib246","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.chest.2018.09.011","article-title":"A\u00a0simple clinical risk score (C2HEST) for predicting incident atrial fibrillation in asian subjects: derivation in 471,446 Chinese subjects, with internal validation and external application in 451,199 Korean subjects","volume":"155","author":"Li","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib247","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2020.03.036","article-title":"Prediction of new-onset atrial fibrillation for general population in Asia: a comparison of C2HEST and HATCH scores","volume":"313","author":"Hu","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib248","doi-asserted-by":"crossref","DOI":"10.2196\/26161","article-title":"Impact of mobile health devices for the detection of atrial fibrillation: systematic review","volume":"9","author":"Biersteker","year":"2021","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.jacc.2023.08.017_bib249","first-page":"1523","article-title":"Serial 7-day electrocardiogram patch screening for AF in high-risk older women by the CHARGE-AF score","volume":"8","author":"Lin","year":"2022","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib250","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0140-6736(22)01637-3","article-title":"Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial","volume":"400","author":"Noseworthy","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib251","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib252","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib253","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2018.02.051","article-title":"Risk factors for new-onset atrial fibrillation: a focus on Asian populations","volume":"261","author":"Li","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib254","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/01.CIR.0000068313.67758.4F","article-title":"Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis","volume":"107","author":"Koyama","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib255","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib256","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/echo.13184","article-title":"Clinical relevance of left atrial strain to predict recurrence of atrial fibrillation after catheter ablation: a meta-analysis","volume":"33","author":"Ma","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.jacc.2023.08.017_bib257","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2015.01.060","article-title":"Left atrial volume is more important than the type of atrial fibrillation in predicting the long-term success of catheter ablation","volume":"184","author":"Costa","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib258","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155581","article-title":"Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"11","author":"Shang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib259","first-page":"e1142","article-title":"Link between non-alcoholic fatty liver disease and atrial fibrillation: a systematic review and meta-analysis","volume":"9","author":"Minhas","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.jacc.2023.08.017_bib260","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","article-title":"Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study","volume":"164","author":"Frost","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib261","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jacc.2007.05.035","article-title":"The value of myocardial perfusion single-photon emission computed tomography in screening asymptomatic patients with atrial fibrillation for coronary artery disease","volume":"50","author":"Askew","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib262","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1001\/jamainternmed.2015.4802","article-title":"Low yield of myocardial perfusion imaging in asymptomatic patients with atrial fibrillation","volume":"175","author":"Cremer","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib263","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1538-7836.2011.04608.x","article-title":"Is atrial fibrillation associated with pulmonary embolism?","volume":"10","author":"Gex","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib264","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.jacc.2017.10.063","article-title":"Structure and function of the left atrium and left atrial appendage: AF and stroke implications","volume":"70","author":"Delgado","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib265","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib266","doi-asserted-by":"crossref","DOI":"10.2196\/26167","article-title":"Diagnostic accuracy of ambulatory devices in detecting atrial fibrillation: systematic review and meta-analysis","volume":"9","author":"Yang","year":"2021","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.jacc.2023.08.017_bib267","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.acvd.2020.05.015","article-title":"Diagnostic accuracy of smart gadgets\/wearable devices in detecting atrial fibrillation: a systematic review and meta-analysis","volume":"114","author":"Prasitlumkum","year":"2021","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib268","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/heartjnl-2020-316611","article-title":"Diagnostic accuracy of handheld electrocardiogram devices in detecting atrial fibrillation in adults in community versus hospital settings: a systematic review and meta-analysis","volume":"106","author":"Wong","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib269","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12141","article-title":"Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study","volume":"24","author":"Kapa","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib270","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/europace\/euv367","volume":"18","author":"Podd","year":"2016","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib271","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/europace\/eul112","article-title":"Verification of pacemaker automatic mode switching for the detection of atrial fibrillation and atrial tachycardia with Holter recording","volume":"8","author":"de Voogt","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib272","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10840-019-00515-0","article-title":"A\u00a0randomized trial evaluating the accuracy of AF detection by four external ambulatory ECG monitors compared to permanent pacemaker AF detection","volume":"57","author":"Eysenck","year":"2020","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib273","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejim.2021.05.038","article-title":"Device-detected atrial high rate episodes and the risk of stroke\/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis","volume":"92","author":"Vitolo","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib274","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib275","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1001\/jama.2021.6128","article-title":"Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke: the PER DIEM randomized clinical trial","volume":"325","author":"Buck","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib276","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/jama.2021.6470","article-title":"Effect of long-term continuous cardiac monitoring vs usual care on detection of atrial fibrillation in patients with stroke attributed to large- or small-vessel disease: the STROKE-AF randomized clinical trial","volume":"325","author":"Bernstein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib277","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41591-018-0268-3","article-title":"Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network","volume":"25","author":"Hannun","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib278","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/jce.14160","article-title":"Recurrent atrial fibrillation\/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results","volume":"30","author":"Goldenthal","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib279","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/heartjnl-2021-320417","article-title":"Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis","volume":"108","author":"Gill","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamacardio.2018.0136","article-title":"Passive detection of atrial fibrillation using a commercially available smartwatch","volume":"3","author":"Tison","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib281","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib282","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.08.019","article-title":"Mobile Photoplethysmographic technology to detect atrial fibrillation","volume":"74","author":"Guo","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib283","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.hrthm.2021.03.044","article-title":"Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatch","volume":"18","author":"Avram","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib284","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCEP.114.002521","article-title":"Electrocardiographic monitoring for detecting atrial fibrillation after ischemic stroke or transient ischemic attack: systematic review and meta-analysis","volume":"8","author":"Dussault","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/JCN.0000000000000646","article-title":"Mobile electrocardiogram monitoring and health-related quality of life in patients with atrial fibrillation: findings from the iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology (iHEART) study","volume":"35","author":"Caceres","year":"2020","journal-title":"J\u00a0Cardiovasc Nurs"},{"key":"10.1016\/j.jacc.2023.08.017_bib286","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2010.02.029","article-title":"The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study)","volume":"55","author":"Tedrow","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib287","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/eurheartj\/ehz897","article-title":"Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort","volume":"41","author":"Elliott","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib288","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2017.05.133","article-title":"Alcohol and incident atrial fibrillation - a systematic review and meta-analysis","volume":"246","author":"Gallagher","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib289","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/2047487318780435","article-title":"Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Aune","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib290","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","article-title":"Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","volume":"32","author":"Aune","year":"2018","journal-title":"J\u00a0Diabetes Complications"},{"key":"10.1016\/j.jacc.2023.08.017_bib291","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.08.017_bib292","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib293","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/europace\/euaa005","article-title":"Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis","volume":"22","author":"Himmelreich","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib294","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41588-018-0133-9","article-title":"Multi-ethnic genome-wide association study for atrial fibrillation","volume":"50","author":"Roselli","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2023.08.017_bib295","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCULATIONAHA.110.009035","article-title":"Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Huxley","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib296","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2017.09.033","article-title":"Usefulness of the American Heart Association's Life Simple 7 to predict the risk of atrial fibrillation (from the REasons for Geographic And Racial Differences in Stroke [REGARDS] study)","volume":"121","author":"Garg","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib297","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1177\/2047487318782379","article-title":"Individual and combined impact of lifestyle factors on atrial fibrillation in apparently healthy men and women: the EPIC-Norfolk prospective population study","volume":"25","author":"Di Benedetto","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"10.1016\/j.jacc.2023.08.017_bib298","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib299","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1093\/eurheartj\/ehac558","article-title":"Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation","volume":"43","author":"Lin","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib300","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.hrthm.2020.12.017","article-title":"Self-reported physical activity and atrial fibrillation risk: a systematic review and meta-analysis","volume":"18","author":"Mishima","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib301","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49686-w","article-title":"Physical activity and risk of atrial fibrillation: a nationwide cohort study in general population","volume":"9","author":"Jin","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib302","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/eurheartj\/ehab250","article-title":"Accelerometer-derived physical activity and risk of atrial fibrillation","volume":"42","author":"Khurshid","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib303","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1161\/CIRCULATIONAHA.117.032432","article-title":"Associations of fitness, physical activity, strength, and genetic risk with cardiovascular disease: longitudinal analyses in the UK Biobank study","volume":"137","author":"Tikkanen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib304","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCULATIONAHA.114.014833","article-title":"Cardiorespiratory fitness and risk of incident atrial fibrillation results from the Henry Ford exercise testing (FIT) project","volume":"131","author":"Qureshi","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib305","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.hrthm.2015.03.024","article-title":"Cardiorespiratory fitness and atrial fibrillation: a population-based follow-up study","volume":"12","author":"Khan","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib306","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1093\/eurheartj\/eht188","article-title":"Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study","volume":"34","author":"Andersen","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib307","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/eurheartj\/ehm555","article-title":"Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists","volume":"29","author":"Baldesberger","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib308","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bjsports-2021-103994","article-title":"Risk of atrial fibrillation in athletes: a systematic review and meta-analysis","volume":"55","author":"Newman","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib309","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/eurheartj\/ehw059","article-title":"Physical activity, resting heart rate, and atrial fibrillation: the Troms\u00f8 study","volume":"37","author":"Morseth","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib310","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.7326\/M21-0228","article-title":"Acute consumption of alcohol and discrete atrial fibrillation events","volume":"174","author":"Marcus","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib311","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijcard.2021.01.071","article-title":"Acute electrical, autonomic and structural effects of binge drinking: insights into the 'holiday heart syndrome","volume":"331","author":"Voskoboinik","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib312","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jacc.2016.10.048","article-title":"Alcohol abuse and cardiac disease","volume":"69","author":"Whitman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib313","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/eurheartj\/ehaa953","article-title":"Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes","volume":"42","author":"Csengeri","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib314","first-page":"1561","article-title":"Risk Thresholds for total and beverage-specific alcohol consumption and incident atrial fibrillation","volume":"7","author":"Tu","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib315","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/joim.12689","article-title":"Smoking, plasma cotinine and risk of atrial fibrillation: the Hordaland Health Study","volume":"283","author":"Zuo","year":"2018","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib316","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12920-021-00915-0","article-title":"Genetically determined tobacco and alcohol use and risk of atrial fibrillation","volume":"14","author":"Lu","year":"2021","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jacc.2023.08.017_bib317","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","article-title":"Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases","volume":"262","author":"Larsson","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib318","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170955","article-title":"Serum glycated hemoglobin level as a predictor of atrial fibrillation: a systematic review with meta-analysis and meta-regression","volume":"12","author":"Qi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib319","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib320","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib321","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib322","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib323","first-page":"139","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib324","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.hrthm.2012.08.043","article-title":"Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation","volume":"10","author":"Abed","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.04.058","article-title":"Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity","volume":"66","author":"Mahajan","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib326","first-page":"630","article-title":"Atrial fibrillation and obesity: reverse remodeling of atrial substrate with weight reduction","volume":"7","author":"Mahajan","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib327","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12933-014-0170-3","article-title":"Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study","volume":"14","author":"Grundvold","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2023.08.017_bib328","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1177\/2047487318782379","article-title":"Individual and combined impact of lifestyle factors on atrial fibrillation in apparently healthy men and women: the EPIC-Norfolk prospective population study","volume":"25","author":"Di Benedetto","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib329","article-title":"Impact of body mass index on the outcomes of catheter ablation of atrial fibrillation: a European observational multicenter study","volume":"8","author":"Provid\u00eancia","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib330","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/heartjnl-2018-313490","article-title":"Impact of body mass index on the outcome of catheter ablation of atrial fibrillation","volume":"105","author":"Glover","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib331","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007598","article-title":"Outcomes of atrial fibrillation ablation in morbidly obese patients following bariatric surgery compared with a nonobese cohort","volume":"12","author":"Donnellan","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib332","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/europace\/euz183","article-title":"Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation","volume":"21","author":"Donnellan","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib333","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007626","article-title":"Impact of bariatric surgery on atrial fibrillation type","volume":"13","author":"Donnellan","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib334","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/jce.14607","article-title":"Impact of risk-factor modification on arrhythmia recurrence among morbidly obese patients undergoing atrial fibrillation ablation","volume":"31","author":"Donnellan","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/jce.13394","article-title":"Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation","volume":"29","author":"Mohanty","year":"2018","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib336","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2006.03.034","article-title":"Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation","volume":"116","author":"Hegbom","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib337","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.115.018220","article-title":"Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial","volume":"133","author":"Malmo","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib338","first-page":"455","article-title":"An exercise and physical activity program in patients with atrial fibrillation: the ACTIVE-AF randomized controlled trial","volume":"9","author":"Elliott","year":"2023","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib339","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study","volume":"66","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib340","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/HCR.0000000000000665","article-title":"Effects of supervised exercise training on atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"42","author":"Oesterle","year":"2022","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.jacc.2023.08.017_bib341","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ahj.2011.09.013","article-title":"A\u00a0randomized study of the effects of exercise training on patients with atrial fibrillation","volume":"162","author":"Osbak","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib342","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003659","article-title":"Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: a nationwide population-based cohort study","volume":"18","author":"Ahn","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib343","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170060","article-title":"Cardiovascular exercise and burden of arrhythmia in patients with atrial fibrillation - a randomized controlled trial","volume":"12","author":"Skielboe","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib344","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/europace\/eup197","article-title":"Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis","volume":"11","author":"Abdulla","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib345","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1093\/eurheartj\/eht188","article-title":"Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study","volume":"34","author":"Andersen","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib346","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000880","article-title":"Exercise-based cardiac rehabilitation improves exercise capacity and health-related quality of life in people with atrial fibrillation: a systematic review and meta-analysis of randomised and non-randomised trials","volume":"5","author":"Smart","year":"2018","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib347","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ahj.2016.08.013","article-title":"Cardiac rehabilitation versus usual care for patients treated with catheter ablation for atrial fibrillation: results of the randomized CopenHeartRFA trial","volume":"181","author":"Risom","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib348","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1177\/2047487319859974","article-title":"Exercise-based cardiac rehabilitation for patients with catheter ablation for persistent atrial fibrillation: a randomized controlled clinical trial","volume":"26","author":"Kato","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib349","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2017.01.032","article-title":"Exercise Training in patients with chronic heart failure and atrial fibrillation","volume":"69","author":"Luo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib350","article-title":"Exercise-based cardiac rehabilitation and all-cause mortality among patients with atrial fibrillation","volume":"10","author":"Buckley","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib351","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib352","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/M15-0171","article-title":"Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force","volume":"163","author":"Patnode","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib353","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12889-020-8275-y","article-title":"Association of smoking cessation after atrial fibrillation diagnosis on the risk of cardiovascular disease: a cohort study of South Korean men","volume":"20","author":"Choi","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2023.08.017_bib354","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/cvr\/cvaa344","article-title":"Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease","volume":"118","author":"Benz","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib355","first-page":"552","article-title":"Modifiable risk factors for incident heart failure in atrial fibrillation","volume":"5","author":"Chatterjee","year":"2017","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.08.017_bib356","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ahj.2016.11.008","article-title":"Multimorbidity and the risk of hospitalization and death in atrial fibrillation: a population-based study","volume":"185","author":"Chamberlain","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib357","article-title":"Provider-level variation in smoking cessation assistance provided in the cardiology clinics: insights from the NCDR PINNACLE registry","volume":"8","author":"Sardana","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib358","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/tobaccocontrol-2011-050124","article-title":"Who receives prescriptions for smoking cessation medications? An association rule mining analysis using a large primary care database","volume":"22","author":"Huang","year":"2013","journal-title":"Tob Control"},{"key":"10.1016\/j.jacc.2023.08.017_bib359","first-page":"CD000165","article-title":"Physician advice for smoking cessation","volume":"5","author":"Stead","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib360","first-page":"CD013229","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis","volume":"1","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib361","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.115.002458","article-title":"Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials","volume":"10","author":"Suissa","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib362","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jce.12936","article-title":"Catheter ablation for\u00a0\"lone\" atrial fibrillation: efficacy and predictors of recurrence","volume":"27","author":"Buiatti","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib363","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jce.13451","article-title":"Cigarette smoking causes a worse long-term outcome in persistent atrial fibrillation following catheter ablation","volume":"29","author":"Cheng","year":"2018","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib364","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT(2)R(2) score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib365","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.13-1740","article-title":"The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study","volume":"145","author":"Albertsen","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib366","first-page":"2238","article-title":"Smoking cessation after diagnosis of new-onset atrial fibrillation and the risk of stroke and death","volume":"10","author":"Lee","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib367","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib368","first-page":"662","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of intravenous alcohol to assess changes in atrial electrophysiology","volume":"7","author":"Marcus","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib369","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2021.5010","article-title":"Individualized studies of triggers of paroxysmal atrial fibrillation: the I-STOP-AFib randomized clinical trial","volume":"7","author":"Marcus","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib370","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.7326\/M21-0228","article-title":"Acute consumption of alcohol and discrete atrial fibrillation events","volume":"174","author":"Marcus","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib371","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib372","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib373","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib374","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib375","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/EJA.0000000000000824","article-title":"Peri-operative oral caffeine does not prevent postoperative atrial fibrillation after heart valve surgery with cardiopulmonary bypass: a randomised controlled clinical trial","volume":"35","author":"Lagier","year":"2018","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib376","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamacardio.2021.5010","article-title":"Individualized Studies of triggers of paroxysmal atrial fibrillation: the I-STOP-AFib randomized clinical trial","volume":"7","author":"Marcus","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib377","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/heartjnl-2013-303950","article-title":"Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"99","author":"Caldeira","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib378","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3945\/ajcn.2010.29627","article-title":"Caffeine consumption and incident atrial fibrillation in women","volume":"92","author":"Conen","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2023.08.017_bib379","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/2047487320909065","article-title":"Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts","volume":"28","author":"Bazal","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib380","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12916-015-0447-8","article-title":"Coffee consumption is not associated with increased risk of atrial fibrillation: results from two prospective cohorts and a meta-analysis","volume":"13","author":"Larsson","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib381","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cjca.2013.12.026","article-title":"Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies","volume":"30","author":"Cheng","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib382","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jamainternmed.2021.3616","article-title":"Coffee consumption and incident tachyarrhythmias: reported behavior, Mendelian randomization, and their interactions","volume":"181","author":"Kim","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib383","article-title":"Coffee consumption and risk of atrial fibrillation in the physicians' health study","volume":"8","author":"Bodar","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib384","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.hrthm.2019.01.027","article-title":"Patient-reported triggers of paroxysmal atrial fibrillation","volume":"16","author":"Groh","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib385","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.numecd.2019.07.015","article-title":"No association between coffee consumption and risk of atrial fibrillation: a Mendelian randomization study","volume":"29","author":"Yuan","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib386","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.clnu.2017.05.002","article-title":"Energy drinks and atrial fibrillation in young adults","volume":"37","author":"Mattioli","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jacc.2023.08.017_bib387","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1752-1947-5-18","article-title":"Atrial fibrillation in healthy adolescents after highly caffeinated beverage consumption: two case reports","volume":"5","author":"Di Rocco","year":"2011","journal-title":"J\u00a0Med Case Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib388","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2459\/JCM.0b013e3282f64554","article-title":"Effect of coffee consumption, lifestyle and acute life stress in the development of acute lone atrial fibrillation","volume":"9","author":"Mattioli","year":"2008","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jacc.2023.08.017_bib389","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurjhf\/hft103","article-title":"n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial","volume":"15","author":"Aleksova","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib390","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ejcn.2013.215","article-title":"U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgery","volume":"68","author":"Metcalf","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jacc.2023.08.017_bib391","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.121.055654","article-title":"Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis","volume":"144","author":"Gencer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib392","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.amjcard.2014.10.022","article-title":"Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation","volume":"115","author":"Darghosian","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib393","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.2010.1735","article-title":"Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial","volume":"304","author":"Kowey","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib394","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2014.07.956","article-title":"Fish oil for the reduction of atrial fibrillation recurrence, inflammation, and oxidative stress","volume":"64","author":"Nigam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib395","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1016\/j.ijcard.2013.06.030","article-title":"Effects of long-term \u03c9-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: results from a prospective randomised study","volume":"168","author":"Kumar","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib396","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2021.1489","article-title":"Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: a randomized clinical trial","volume":"325","author":"Albert","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib397","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.hjc.2017.11.006","article-title":"Vitamin D and new-onset atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"59","author":"Huang","year":"2018","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib398","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11748-019-01209-0","article-title":"Effects of high-dose vitamin D supplementation on the occurrence of post-operative atrial fibrillation after coronary artery bypass grafting: randomized controlled trial","volume":"68","author":"Kara","year":"2020","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib399","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/clc.22951","article-title":"Sole and combined vitamin C supplementation can prevent postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of randomized controlled trials","volume":"41","author":"Shi","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib400","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib401","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib402","article-title":"Low-carbohydrate diets and risk of incident atrial fibrillation: a prospective cohort study","volume":"8","author":"Zhang","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib403","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jacc.2017.07.755","article-title":"Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry","volume":"70","author":"Echouffo-Tcheugui","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib404","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2876","article-title":"Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: a study-level meta-analysis of phase III randomized trials","volume":"33","author":"Patti","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib405","first-page":"897","article-title":"Association between pre-ablation glycemic control and outcomes among patients with diabetes undergoing atrial fibrillation ablation","volume":"5","author":"Donnellan","year":"2019","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib406","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib407","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib408","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib409","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib411","article-title":"Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: data from ROCKET AF","volume":"5","author":"Pokorney","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib412","article-title":"Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial","volume":"4","author":"Rao","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib413","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/CIRCULATIONAHA.116.026230","article-title":"Effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: a randomized, open-label clinical trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])","volume":"135","author":"Parkash","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib414","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/HYPERTENSIONAHA.120.14766","article-title":"Effect of intensive blood pressure lowering on the risk of atrial fibrillation","volume":"75","author":"Soliman","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2023.08.017_bib415","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/eurheartj\/ehy877","article-title":"Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population","volume":"40","author":"Kim","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib416","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib417","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cjca.2021.09.026","article-title":"Prevalence and assessment of sleep-disordered breathing in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"37","author":"Kadhim","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib418","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.5664\/jcsm.9098","article-title":"Clinical screening tools for obstructive sleep apnea in a population with atrial fibrillation: a diagnostic accuracy trial","volume":"17","author":"Mohammadieh","year":"2021","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib419","first-page":"692","article-title":"Variability of sleep apnea severity and risk of atrial fibrillation: the VARIOSA-AF study","volume":"5","author":"Linz","year":"2019","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib420","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/clc.22933","article-title":"The prevalence of obstructive sleep apnea in patients with atrial fibrillation","volume":"41","author":"Abumuamar","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib421","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11325-017-1469-6","article-title":"Stratification of cardiovascular risk in patients with atrial fibrillation and obstructive sleep apnea-validity of the 2MACE score","volume":"21","author":"Platek","year":"2017","journal-title":"Sleep Breath"},{"key":"10.1016\/j.jacc.2023.08.017_bib422","article-title":"Effects of continuous positive airway pressure treatment in obstructive sleep apnea patients with atrial fibrillation: a meta-analysis","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2023.08.017_bib423","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10840-020-00738-6","article-title":"CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis","volume":"58","author":"Yang","year":"2020","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib424","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jebm.12313","article-title":"Effect of obstructive sleep apnea and its treatment of atrial fibrillation recurrence after radiofrequency catheter ablation: a meta-analysis","volume":"11","author":"Congrete","year":"2018","journal-title":"J\u00a0Evid Based Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib425","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.sleep.2018.02.013","article-title":"Treating obstructive sleep apnea with continuous positive airway pressure reduces risk of recurrent atrial fibrillation after catheter ablation: a meta-analysis","volume":"46","author":"Deng","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib426","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.amjcard.2015.08.046","article-title":"Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea","volume":"116","author":"Qureshi","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib427","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11325-014-1102-x","article-title":"Presence and severity of obstructive sleep apnea and remote outcomes of atrial fibrillation ablations - a long-term prospective, cross-sectional cohort study","volume":"19","author":"Szymanski","year":"2015","journal-title":"Sleep Breath"},{"key":"10.1016\/j.jacc.2023.08.017_bib428","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijcard.2018.11.100","article-title":"The impact of continuous positive airway pressure treatment on the recurrence of atrial fibrillation post cardioversion: a randomized controlled trial","volume":"278","author":"Caples","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib429","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.202011-4133OC","article-title":"Effect of continuous positive airway pressure on arrhythmia in atrial fibrillation and sleep apnea: a randomized controlled trial","volume":"204","author":"Traaen","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib430","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.hrthm.2019.09.001","article-title":"Incidence of sleep apnea and association with atrial fibrillation in an unselected pacemaker population: results of the observational RESPIRE study","volume":"17","author":"Marti-Almor","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib431","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.amjcard.2018.08.032","article-title":"Extended cardiac monitoring in patients with severe sleep apnea and no history of atrial fibrillation (the Reveal XT-SA study)","volume":"122","author":"Yeung","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib432","article-title":"Association between sleep apnea hypopnea syndrome and the risk of atrial fibrillation: a meta-analysis of cohort study","volume":"2018","author":"Zhao","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jacc.2023.08.017_bib433","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.201508-1523OC","article-title":"Central sleep-disordered breathing predicts incident atrial fibrillation in older men","volume":"193","author":"May","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib434","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1253\/circj.CJ-14-0222","article-title":"Incidence and risk of atrial fibrillation in sleep-disordered breathing without coexistent systemic disease","volume":"78","author":"Chao","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2023.08.017_bib435","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.hrthm.2018.05.008","article-title":"Sleep characteristics that predict atrial fibrillation","volume":"15","author":"Christensen","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib436","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.chest.2019.01.033","article-title":"Association of short sleep duration and atrial fibrillation","volume":"156","author":"Genuardi","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib437","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjcard.2021.06.010","article-title":"Risk factors and lifestyles in the development of atrial fibrillation among individuals aged 20-39 years","volume":"155","author":"Itoh","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib438","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.hrthm.2022.06.016","article-title":"Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: a randomized controlled trial","volume":"19","author":"Hunt","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib439","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib440","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib441","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib442","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","article-title":"Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation","volume":"33","author":"Hendriks","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib443","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","article-title":"Mobile health technology to improve care for patients with atrial fibrillation","volume":"75","author":"Guo","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib444","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002528","article-title":"A\u00a0clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: a cluster-randomized trial in a Swedish primary care setting (the CDS-AF study)","volume":"15","author":"Karlsson","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib445","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.hrthm.2020.04.033","article-title":"Rationale, considerations, and goals for atrial fibrillation centers of excellence: a Heart Rhythm Society perspective","volume":"17","author":"Piccini","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib446","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/clc.23001","article-title":"The role and outcome of cardiac rehabilitation program in patients with atrial fibrillation","volume":"41","author":"Younis","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib447","first-page":"1187","article-title":"The Atrial Fibrillation Therapies after ER visit: Outpatient Care for Patients with Acute AF - the AFTER3 study","volume":"7","author":"Angaran","year":"2015","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.jacc.2023.08.017_bib448","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/eurheartj\/ehz666","article-title":"Nurse-led vs. usual-care for atrial fibrillation","volume":"41","author":"Wijtvliet","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib449","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1093\/eurheartj\/ehaa055","article-title":"Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial","volume":"41","author":"van den Dries","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib450","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(14)61992-9","article-title":"Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial","volume":"385","author":"Stewart","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib451","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003045","article-title":"An adaptable implementation package targeting evidence-based indicators in primary care: a pragmatic cluster-randomised evaluation","volume":"17","author":"Willis","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib452","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2020.02.019","article-title":"Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): a cluster randomized trial of a computerized clinical decision support tool","volume":"224","author":"Cox","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib453","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170974","article-title":"Effectiveness and usage of a decision support system to improve stroke prevention in general practice: a cluster randomized controlled trial","volume":"12","author":"Arts","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib454","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(17)32165-7","article-title":"A\u00a0multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial","volume":"390","author":"Vinereanu","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib455","article-title":"A\u00a0new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib456","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib457","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017157","article-title":"Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation","volume":"7","author":"Fox","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib458","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/CIRCULATIONAHA.116.024057","article-title":"Wide variation in reported rates of stroke across cohorts of patients with atrial fibrillation","volume":"135","author":"Quinn","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib459","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib460","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib461","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A\u00a0new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib462","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib463","first-page":"1384","article-title":"Ischemic and bleeding outcomes in patients with atrial fibrillation and contraindications to oral anticoagulation","volume":"5","author":"Steinberg","year":"2019","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib464","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1636534","article-title":"Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS-BLED scores with an approach focused on modifiable bleeding risk factors","volume":"118","author":"Chao","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib465","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib466","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1016\/j.jacc.2019.10.040","article-title":"Ischemic stroke risk in patients with nonvalvular atrial fibrillation: JACC review topic of the week","volume":"74","author":"Alkhouli","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib467","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1161\/STROKEAHA.115.010947","article-title":"Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi Atrial Fibrillation Registry","volume":"46","author":"Takabayashi","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib468","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib469","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.757087","article-title":"Diagnostic accuracy of the HAS-BLED bleeding score in VKA- or DOAC-treated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"8","author":"Gao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib470","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijcard.2016.11.015","article-title":"Meta-analysis of ATRIA versus CHA(2)DS(2)-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation","volume":"227","author":"Zhu","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib471","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2015.08.033","article-title":"Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: results from a national primary care database","volume":"66","author":"van den Ham","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib472","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033283","article-title":"GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study","volume":"9","author":"Dalgaard","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib473","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/europace\/euac096","article-title":"Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation","volume":"24","author":"van der Endt","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib474","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/jth.14692","article-title":"Accuracy of HAS-BLED and other bleeding risk assessment tools in predicting major bleeding events in atrial fibrillation: a network meta-analysis","volume":"18","author":"Chang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib475","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2016.04.173","article-title":"Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation. A French nationwide cross-sectional study","volume":"217","author":"Fauchier","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib476","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/M17-2762","article-title":"Effect of variation in published stroke rates on the net clinical benefit of anticoagulation for atrial fibrillation","volume":"169","author":"Shah","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib477","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamacardio.2018.1176","article-title":"Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study","volume":"3","author":"Go","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib478","article-title":"Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial","volume":"4","author":"Rao","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib479","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib480","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/STROKEAHA.116.013880","article-title":"Validation of a modified CHA2DS2-VASc score for stroke risk stratification in Asian patients with atrial fibrillation: a nationwide cohort study","volume":"47","author":"Chao","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib481","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","article-title":"Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial","volume":"34","author":"Al-Khatib","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib482","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004267","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: results from the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)","volume":"10","author":"Link","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib483","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib484","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1636534","article-title":"Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS-BLED scores with an approach focused on modifiable bleeding risk factors","volume":"118","author":"Chao","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib485","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11239-016-1377-9","article-title":"Renal function in atrial fibrillation patients switched from warfarin to a direct oral anticoagulant","volume":"42","author":"Minhas","year":"2016","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2023.08.017_bib486","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1055\/s-0038-1651482","article-title":"Dynamic changes of CHA2DS2-VASc score and the risk of ischaemic stroke in Asian patients with atrial fibrillation: a nationwide cohort study","volume":"118","author":"Yoon","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib487","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/phar.2158","article-title":"Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010-2017","volume":"38","author":"Zhu","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2023.08.017_bib488","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib489","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib490","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib491","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib492","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib493","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib494","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib495","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib496","doi-asserted-by":"crossref","first-page":"j5058","DOI":"10.1136\/bmj.j5058","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"Bmj"},{"key":"10.1016\/j.jacc.2023.08.017_bib497","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib498","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib499","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib500","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib501","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","article-title":"Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial","volume":"37","author":"Sato","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib502","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib503","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib504","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1093\/eurheartj\/ehw077","article-title":"Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation","volume":"37","author":"Aspberg","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib505","article-title":"A\u00a0new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib506","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib507","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib508","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.jacc.2020.08.044","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib509","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/1060028020970618","article-title":"Off-label use for direct oral anticoagulants: valvular atrial fibrillation, heart failure, left ventricular thrombus, superficial vein thrombosis, pulmonary hypertension-a systematic review","volume":"55","author":"Brokmeier","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2023.08.017_bib510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000016023","article-title":"Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies","volume":"10","author":"Hart","year":"2000","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib511","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/bcp.12075","article-title":"Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects","volume":"76","author":"Mueck","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib512","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bcp.12541","article-title":"Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor","volume":"79","author":"Frost","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib513","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/bcp.13092","article-title":"Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine","volume":"82","author":"Parasrampuria","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib514","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40263-021-00795-z","article-title":"Effect of enzyme-inducing antiseizure medications on the risk of sub-therapeutic concentrations of direct oral anticoagulants: a retrospective cohort study","volume":"35","author":"Perlman","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jacc.2023.08.017_bib515","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40256-015-0157-9","article-title":"Effect of rifampin on the pharmacokinetics of apixaban, an oral direct inhibitor of factor Xa","volume":"16","author":"Vakkalagadda","year":"2016","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2023.08.017_bib516","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s40263-019-00677-5","article-title":"Ischemic and thrombotic events associated with concomitant Xa-inhibiting direct oral anticoagulants and antiepileptic drugs: analysis of the FDA Adverse Event Reporting System (FAERS)","volume":"33","author":"Perlman","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jacc.2023.08.017_bib517","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40261-020-00982-8","article-title":"Concomitant use of direct oral anticoagulants and antiepileptic drugs: a prospective cohort study in patients with atrial fibrillation","volume":"41","author":"Giustozzi","year":"2021","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jacc.2023.08.017_bib518","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCOUTCOMES.108.796185","article-title":"Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review","volume":"1","author":"Wan","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib519","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.109.849208","article-title":"Improved oral anticoagulation after a dietary vitamin K-guided strategy: a randomized controlled trial","volume":"120","author":"De Assis","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib520","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1111\/bcp.14833","article-title":"Drug\u2013drug interactions with warfarin: a systematic review and meta-analysis","volume":"87","author":"Wang","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib521","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.japh.2021.10.027","article-title":"Meta-analysis comparing inappropriately low dose versus standard dose of direct oral anticoagulants in patients with atrial fibrillation","volume":"62","author":"Kido","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.jacc.2023.08.017_bib522","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007971","article-title":"Off-label under- and overdosing of direct oral anticoagulants in patients with atrial fibrillation: a meta-analysis","volume":"14","author":"Zhang","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib523","series-title":"Eliquis [package insert]","year":"2021"},{"key":"10.1016\/j.jacc.2023.08.017_bib524","series-title":"Pradaxa [package insert]","year":"2021"},{"key":"10.1016\/j.jacc.2023.08.017_bib525","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.amjcard.2020.12.062","article-title":"Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation","volume":"144","author":"Sugrue","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib526","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.028","article-title":"The comparison of inappropriate-low-doses use among 4 direct oral anticoagulants in patients with atrial fibrillation: from the database of a single-center registry","volume":"27","author":"Sato","year":"2018","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib527","article-title":"Label adherence of direct oral anticoagulants dosing and clinical outcomes in patients with atrial fibrillation","volume":"9","author":"Yu","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib528","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2020.07.045","article-title":"Mortality in patients with atrial fibrillation receiving nonrecommended doses of direct oral anticoagulants","volume":"76","author":"Camm","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib529","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5414\/CP201812","article-title":"The effect of food on the absorption and pharmacokinetics of rivaroxaban","volume":"51","author":"Stampfuss","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib530","series-title":"Xarelto [package insert]","year":"2023"},{"key":"10.1016\/j.jacc.2023.08.017_bib531","series-title":"Savaysa [package insert]","year":"2021"},{"key":"10.1016\/j.jacc.2023.08.017_bib532","series-title":"Coumadin [package insert]","year":"2012"},{"key":"10.1016\/j.jacc.2023.08.017_bib533","series-title":"CardSAP 2021; Book 2. Arrhythmias and Thrombosis","first-page":"32","article-title":"Atrial fibrillation\/atrial flutter: stroke prevention","author":"Kido","year":"2021"},{"key":"10.1016\/j.jacc.2023.08.017_bib534","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib535","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1056\/NEJMcp1503946","article-title":"CLINICAL PRACTICE. Cryptogenic stroke","volume":"374","author":"Saver","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib536","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11886-021-01604-1","article-title":"Stroke prevention after cryptogenic stroke","volume":"23","author":"Ibeh","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib537","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1007\/s10072-020-04963-9","article-title":"Prevalence and predictors of atrial fibrillation in patients with embolic stroke of undetermined source: a real-life single-center retrospective study","volume":"42","author":"Melis","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jacc.2023.08.017_bib538","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.4022\/jafib.2078","article-title":"Incidence and predictive factors of hidden atrial fibrillation detected by implantable loop recorder after an embolic stroke of undetermined source","volume":"11","author":"Victor","year":"2018","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.jacc.2023.08.017_bib539","first-page":"987","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"379","author":"Hart","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib540","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib541","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1161\/01.CIR.84.2.527","article-title":"Stroke Prevention in Atrial Fibrillation Study. Final results","volume":"84","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib542","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib543","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","article-title":"Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF(RANDOMISED)): an open-label randomised controlled trial","volume":"16","author":"Wachter","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2023.08.017_bib544","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","article-title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis","volume":"14","author":"Sposato","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jacc.2023.08.017_bib545","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib546","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1001\/jama.2021.6128","article-title":"Effect of implantable vs prolonged external electrocardiographic monitoring on atrial fibrillation detection in patients with ischemic stroke: the per diem randomized clinical trial","volume":"325","author":"Buck","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib547","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib548","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","article-title":"Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score","volume":"140","author":"Kaplan","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib549","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.118.038988","article-title":"Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation","volume":"139","author":"Perino","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib550","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.115.020252","article-title":"Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the registry of atrial tachycardia and atrial fibrillation episodes","volume":"134","author":"Swiryn","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib551","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib552","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/eurheartj\/ehx731","article-title":"Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis","volume":"39","author":"Mahajan","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib553","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/STROKEAHA.120.031822","article-title":"Subclinical atrial fibrillation burden and adverse clinical outcomes in patients with permanent pacemakers","volume":"52","author":"Park","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib554","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib555","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1460-9592.2001.00424.x","article-title":"Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter","volume":"24","author":"Pollak","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib556","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib557","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib558","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","article-title":"Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events","volume":"20","author":"Botto","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib559","doi-asserted-by":"crossref","first-page":"e944","DOI":"10.1161\/CIR.0000000000000740","article-title":"Subclinical and device-detected atrial fibrillation: pondering the knowledge gap: a scientific statement from the American Heart Association","volume":"140","author":"Noseworthy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib560","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrcardio.2017.94","article-title":"Management of atrial high-rate episodes detected by cardiac implanted electronic devices","volume":"14","author":"Freedman","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib561","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib562","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib563","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib564","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib565","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib566","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib567","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib568","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jacc.2022.02.047","article-title":"Antithrombotic therapy after left atrial appendage occlusion in patients with atrial fibrillation","volume":"79","author":"Freeman","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib569","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2017.03.007","article-title":"The assessment of the Watchman device in patients unsuitable for oral anticoagulation (ASAP-TOO) trial","volume":"189","author":"Holmes","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib570","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib571","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.2017.20125","article-title":"Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing concomitant cardiac surgery","volume":"319","author":"Friedman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib572","first-page":"252","article-title":"Beneficial effect of left atrial appendage closure during cardiac surgery: a meta-analysis of 280 585 patients","volume":"57","author":"Mart\u00edn Guti\u00e9rrez","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib573","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ahj.2004.09.054","article-title":"Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke","volume":"150","author":"Healey","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib574","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.hrthm.2015.03.028","article-title":"Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization","volume":"12","author":"Aryana","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib575","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.1949.02900440011003","article-title":"Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli","volume":"140","author":"Madden","year":"1949","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib576","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.116.021952","article-title":"Impact of left atrial appendage closure during cardiac surgery on the occurrence of early postoperative atrial fibrillation, stroke, and mortality","volume":"135","author":"Melduni","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib577","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.amjcard.2017.06.025","article-title":"Impact of left atrial appendage exclusion on cardiovascular outcomes in patients with atrial fibrillation undergoing coronary artery bypass grafting (from the National Inpatient Sample Database)","volume":"120","author":"Elbadawi","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib578","first-page":"252","article-title":"Beneficial effect of left atrial appendage closure during cardiac surgery: a meta-analysis of 280 585 patients","volume":"57","author":"Guti\u00e9rrez","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib579","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.amjcard.2017.03.037","article-title":"Cardiovascular outcomes with surgical left atrial appendage exclusion in patients with atrial fibrillation who underwent valvular heart surgery (from the National Inpatient Sample Database)","volume":"119","author":"Elbadawi","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib580","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.carrev.2021.11.002","article-title":"Left atrial appendage closure during cardiac surgery for atrial fibrillation: a meta-analysis","volume":"40","author":"Prasad","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib581","article-title":"Modification of the left atrial appendage and its role in stroke risk reduction with non-valvular atrial fibrillation","volume":"32","author":"Rashid","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacc.2023.08.017_bib582","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/icvts\/ivz156","article-title":"Outcomes of left atrial appendage occlusion using the AtriClip device: a systematic review","volume":"29","author":"Toale","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib583","article-title":"Outcomes of cardiac surgery with left atrial appendage occlusion versus no occlusion, direct oral anticoagulants, and vitamin K antagonists: a systematic review with meta-analysis","volume":"40","author":"Nso","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacc.2023.08.017_bib584","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13019-018-0740-7","article-title":"Adding left atrial appendage closure to open heart surgery provides protection from ischemic brain injury six years after surgery independently of atrial fibrillation history: the LAACS randomized study","volume":"13","author":"Park-Hansen","year":"2018","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib585","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib586","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCULATIONAHA.118.036710","article-title":"Idarucizumab for dabigatran reversal in the management of patients with gastrointestinal bleeding","volume":"139","author":"Van der Wall","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib587","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2019.07.070","article-title":"Dabigatran reversal with idarucizumab in patients with renal impairment","volume":"74","author":"Eikelboom","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib588","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2017.02.010","article-title":"Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study","volume":"152","author":"Schulman","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib589","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","author":"Eerenberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib590","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet\u00a0alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib591","doi-asserted-by":"crossref","first-page":"e1025","DOI":"10.1097\/CCM.0000000000005059","article-title":"Andexanet\u00a0alfa or prothrombin complex concentrate for factor Xa inhibitor reversal in acute major bleeding: a systematic review and meta-analysis","volume":"49","author":"Nederpelt","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib592","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1160\/TH16-04-0266","article-title":"Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis","volume":"116","author":"Chai-Adisaksopha","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib593","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib594","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(14)61685-8","article-title":"Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial","volume":"385","author":"Goldstein","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib595","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10620-020-06248-9","article-title":"Resuming anticoagulation following hospitalization for gastrointestinal bleeding is associated with reduced thromboembolic events and improved mortality: results from a systematic review and meta-analysis","volume":"66","author":"Tapaskar","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacc.2023.08.017_bib596","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2018.03.053","article-title":"Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: a systematic review and meta-analysis","volume":"261","author":"Proietti","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib597","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/hematology.2019000072","article-title":"What we have learned about direct oral anticoagulant reversal","volume":"2019","author":"Siegal","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jacc.2023.08.017_bib598","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40256-013-0055-y","article-title":"Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects","volume":"14","author":"Wang","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2023.08.017_bib599","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40262-016-0485-1","article-title":"Effect of activated charcoal on rivaroxaban complex absorption","volume":"56","author":"Ollier","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2023.08.017_bib600","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/jth.13117","article-title":"Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review","volume":"13","author":"Chai-Adisaksopha","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib601","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11606-019-05391-y","article-title":"Emergency visits for oral anticoagulant bleeding","volume":"35","author":"Geller","year":"2020","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib602","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1016\/j.jacc.2021.04.061","article-title":"Meta-analysis of reversal agents for severe bleeding associated with direct oral anticoagulants","volume":"77","author":"G\u00f3mez-Outes","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib603","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1160\/TH16-07-0498","article-title":"Optimal timing of vitamin K antagonist resumption after upper gastrointestinal bleeding. A risk modelling analysis","volume":"117","author":"Majeed","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib604","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.amjcard.2013.10.044","article-title":"Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation","volume":"113","author":"Qureshi","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib605","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib606","series-title":"CardSAP 2021; Book 2. Arrhythmias and Thrombosis","first-page":"32","article-title":"Atrial fibrillation\/atrial flutter: stroke prevention","author":"Kido","year":"2021"},{"key":"10.1016\/j.jacc.2023.08.017_bib607","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/ehy056","article-title":"Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves","volume":"39","author":"Kuramatsu","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib608","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.0000000000004235","article-title":"Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation","volume":"89","author":"Korompoki","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2023.08.017_bib609","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","article-title":"Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation","volume":"48","author":"Pennlert","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib610","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/CIRCULATIONAHA.115.015735","article-title":"Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide cohort study","volume":"132","author":"Nielsen","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib611","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","article-title":"Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis","volume":"48","author":"Murthy","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib612","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib613","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib614","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.1.5392.1209","article-title":"Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease","volume":"1","author":"Szekely","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.jacc.2023.08.017_bib615","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","article-title":"Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses","volume":"89","author":"Cannegieter","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib616","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0022-5223(95)70309-8","article-title":"Long-term results of valve replacement with the St. Jude Medical prosthesis","volume":"109","author":"Baudet","year":"1995","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib617","doi-asserted-by":"crossref","first-page":"457S","DOI":"10.1378\/chest.126.3_suppl.457S","article-title":"Antithrombotic therapy in valvular heart disease--native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Salem","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib618","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/STROKEAHA.113.003003","article-title":"Incidence of oral anticoagulant-associated intracerebral hemorrhage in the Netherlands","volume":"45","author":"Schols","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib619","first-page":"3126","article-title":"Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use","volume":"266","author":"Seiffge","year":"2019","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jacc.2023.08.017_bib620","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/NCC:5:3:197","article-title":"Location and outcome of anticoagulant-associated intracerebral hemorrhage","volume":"5","author":"Flaherty","year":"2006","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jacc.2023.08.017_bib621","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/01.WNL.0000138428.40673.83","article-title":"Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage","volume":"63","author":"Flibotte","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2023.08.017_bib622","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/s-0038-1627454","article-title":"Anticoagulants resumption after warfarin-related intracerebral haemorrhage: the Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy)","volume":"118","author":"Poli","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib623","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4244\/EIJ-D-17-00201","article-title":"Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study","volume":"13","author":"Nielsen-Kudsk","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacc.2023.08.017_bib624","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/STROKEAHA.116.012945","article-title":"Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage","volume":"47","author":"Ottosen","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib625","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCULATIONAHA.115.019794","article-title":"Use of Oral anticoagulants for stroke prevention in patients with atrial fibrillation who have a history of intracranial hemorrhage","volume":"133","author":"Chao","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib626","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.hrthm.2016.05.016","article-title":"Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage","volume":"13","author":"Park","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib627","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib628","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.25079","article-title":"Oral anticoagulation and functional outcome after intracerebral hemorrhage","volume":"82","author":"Biffi","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jacc.2023.08.017_bib629","doi-asserted-by":"crossref","first-page":"235","DOI":"10.20452\/pamw.1291","article-title":"Bleeding risk assessment and management in atrial fibrillation patients. Key messages for clinical practice from the European Heart Rhythm Association position statement","volume":"122","author":"Guo","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.jacc.2023.08.017_bib630","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/WNL.0000000000003866","article-title":"Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy","volume":"88","author":"Charidimou","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2023.08.017_bib631","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0735-1097(94)00396-8","article-title":"Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study","volume":"25","author":"Stoddard","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib632","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib633","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib634","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/jce.14599","article-title":"Epicardial standalone left atrial appendage clipping for prevention of ischemic stroke in patients with atrial fibrillation contraindicated for oral anticaogulation","volume":"31","author":"Branzoli","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib635","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.xjtc.2021.07.009","article-title":"Robotics-assisted epicardial left atrial appendage clip exclusion","volume":"9","author":"Antaki","year":"2021","journal-title":"JTCVS Tech"},{"key":"10.1016\/j.jacc.2023.08.017_bib636","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib637","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.medcli.2017.01.023","article-title":"Perioperative management of vitamin K antagonists in patients with low thromboembolic risk undergoing elective surgery: a prospective experience","volume":"149","author":"Becerra","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jacc.2023.08.017_bib638","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.112.105221","article-title":"Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates","volume":"126","author":"Siegal","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib639","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib640","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation","volume":"368","author":"Birnie","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib641","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.hrthm.2010.12.016","article-title":"Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial","volume":"8","author":"Cheng","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib642","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/eurheartj\/ehp194","article-title":"Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial","volume":"30","author":"Tolosana","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib643","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/pace.14091","article-title":"Continued versus interrupted direct oral anticoagulation for cardiac electronic device implantation: a systematic review","volume":"43","author":"Mendoza","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib644","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1093\/eurheartj\/ehy413","article-title":"Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)","volume":"39","author":"Birnie","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib645","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/pace.13482","article-title":"Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: a single-center randomized prospective pilot trial","volume":"41","author":"Ricciardi","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib646","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.thromres.2015.08.006","article-title":"Peri-procedural management of dabigatran and rivaroxaban: duration of anticoagulant discontinuation and drug concentrations","volume":"136","author":"Godier","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2023.08.017_bib647","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1358863X211047270","article-title":"Apixaban Discontinuation for Invasive Or major Surgical procedures (ADIOS): a prospective cohort study","volume":"27","author":"Merli","year":"2022","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib648","doi-asserted-by":"crossref","first-page":"n1205","DOI":"10.1136\/bmj.n1205","article-title":"Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial","volume":"373","author":"Kovacs","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.jacc.2023.08.017_bib649","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.joms.2008.12.027","article-title":"Randomized, prospective trial comparing bridging therapy using low-molecular-weight heparin with maintenance of oral anticoagulation during extraction of teeth","volume":"67","author":"Bajkin","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib650","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.114.011777","article-title":"Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"131","author":"Steinberg","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib651","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force","volume":"69","author":"Doherty","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib652","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/aas.12069","article-title":"Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin)","volume":"57","author":"Rosencher","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jacc.2023.08.017_bib653","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinternmed.2007.23","article-title":"Risk of thromboembolism with short-term interruption of warfarin therapy","volume":"168","author":"Garcia","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib654","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0735-1097(00)00633-1","article-title":"A\u00a0randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation","volume":"35","author":"Michaud","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib655","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/eurheartj\/eht557","article-title":"Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry","volume":"35","author":"Beyer-Westendorf","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib656","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/CIRCULATIONAHA.117.031457","article-title":"Periprocedural outcomes of direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation","volume":"138","author":"Nazha","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib657","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/clc.23379","article-title":"Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: the prospective, observational, and multinational EMIT-AF\/VTE study","volume":"43","author":"Colonna","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib658","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib659","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib660","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib661","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0140-6736(19)31872-0","article-title":"Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial","volume":"394","author":"Vranckx","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib662","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib663","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/europace\/euz259","volume":"22","author":"Potpara","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib664","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib665","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib666","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCULATIONAHA.118.036768","article-title":"Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery disease beyond 1 year after coronary stent implantation","volume":"139","author":"Matsumura-Nakano","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib667","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jcin.2021.07.045","article-title":"Rivaroxaban monotherapy in patients with atrial fibrillation after coronary stenting: insights from the AFIRE trial","volume":"14","author":"Matoba","year":"2021","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2023.08.017_bib668","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1536\/ihj.19-202","article-title":"Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation with coronary or peripheral artery disease","volume":"61","author":"Zhang","year":"2020","journal-title":"Int Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib669","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/eurheartj\/eht492","article-title":"Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF","volume":"35","author":"Jones","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib670","article-title":"Efficacy and safety of apixaban compared with warfarin in patients with atrial fibrillation and peripheral artery disease: insights from the ARISTOTLE trial","volume":"6","author":"Hu","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib671","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/ehjcvp\/pvab089","article-title":"Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48","volume":"8","author":"Bonaca","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2023.08.017_bib672","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ahj.2019.04.007","article-title":"Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: results from the outcomes registry for better informed treatment of atrial fibrillation II","volume":"213","author":"Inohara","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib673","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib674","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","author":"Anand","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib675","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.jacc.2014.03.039","article-title":"Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study","volume":"63","author":"Lamberts","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib676","first-page":"Cd011373","article-title":"Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease","volume":"11","author":"Kimachi","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib677","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M19-0087","article-title":"Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis","volume":"171","author":"Ha","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib678","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2215\/CJN.02400311","article-title":"Warfarin in atrial fibrillation patients with moderate chronic kidney disease","volume":"6","author":"Hart","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.08.017_bib679","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/CIRCULATIONAHA.119.044059","article-title":"Apixaban versus warfarin in patients with atrial fibrillation and advanced chronic kidney disease","volume":"141","author":"Stanifer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib680","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/jama.2014.1334","article-title":"Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation","volume":"311","author":"Carrero","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib681","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2014.09.051","article-title":"Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study","volume":"64","author":"Bonde","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib682","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2175","article-title":"Association between use of warfarin for atrial fibrillation and outcomes among patients with end-stage renal disease: a systematic review and meta-analysis","volume":"3","author":"Randhawa","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib683","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib684","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2020.10.020","article-title":"A\u00a0systematic review of the incidence of arrhythmias in hemodialysis patients undergoing long-term monitoring with implantable loop recorders","volume":"6","author":"Roberts","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib685","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2023.08.017_bib686","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1681\/ASN.2012080841","article-title":"Incidence of stroke before and after dialysis initiation in older patients","volume":"24","author":"Murray","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.08.017_bib687","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/ndt\/gfab060","article-title":"Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion","volume":"37","author":"De Vriese","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2023.08.017_bib688","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/heartjnl-2016-309266","article-title":"Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease","volume":"103","author":"Yang","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib689","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/ndt\/gfr658","article-title":"A\u00a0case-control study of calciphylaxis in Japanese end-stage renal disease patients","volume":"27","author":"Hayashi","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2023.08.017_bib690","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.114.014113","article-title":"Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis","volume":"131","author":"Chan","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib691","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jacc.2023.08.017_bib692","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1681\/ASN.2020111566","article-title":"Safety and efficacy of vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: a multicenter randomized controlled trial","volume":"32","author":"De Vriese","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.08.017_bib693","article-title":"Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: a real-world nationwide cohort study","volume":"16","author":"Lin","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib694","first-page":"63","article-title":"Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis","volume":"34","author":"Genovesi","year":"2021","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jacc.2023.08.017_bib695","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.05.007","article-title":"Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease","volume":"21","author":"Eikelboom","year":"2012","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib696","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.2215\/CJN.04550511","article-title":"Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation","volume":"6","author":"Winkelmayer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.08.017_bib697","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ckj\/sfac022","article-title":"Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3-G5D","volume":"15","author":"Welander","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jacc.2023.08.017_bib698","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib699","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib700","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jcph.628","article-title":"Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis","volume":"56","author":"Wang","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib701","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1681\/ASN.2016090980","article-title":"Apixaban pharmacokinetics at steady state in hemodialysis patients","volume":"28","author":"Mavrakanas","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.08.017_bib702","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib703","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2215\/CJN.11650919","article-title":"Apixaban versus no anticoagulation in patients undergoing long-term dialysis with incident atrial fibrillation","volume":"15","author":"Mavrakanas","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2023.08.017_bib704","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","article-title":"A\u00a0randomized controlled trial comparing apixaban to the vitamin K-antagonist phenprocoumon in patients on chronic hemodialysis: the AXADIA-AFNET 8 study","volume":"147","author":"Reinecke","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib705","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","article-title":"Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial","volume":"146","author":"Pokorney","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib706","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa2209051","article-title":"Rivaroxaban in rheumatic heart disease-associated atrial fibrillation","volume":"387","author":"Connolly","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib707","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib708","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib709","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib710","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib711","doi-asserted-by":"crossref","first-page":"j5058","DOI":"10.1136\/bmj.j5058","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib712","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib713","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib714","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/europace\/euy151","article-title":"Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study","volume":"21","author":"Lip","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib715","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib716","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2023.08.017_bib717","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2018.12.047","article-title":"Outcomes of direct oral anticoagulants in patients with mitral stenosis","volume":"73","author":"Kim","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib718","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/1060028020970618","article-title":"Off-label use for direct oral anticoagulants: valvular atrial fibrillation, heart failure, left ventricular thrombus, superficial vein thrombosis, pulmonary hypertension-a systematic review","volume":"55","author":"Brokmeier","year":"2021","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2023.08.017_bib719","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/CIRCULATIONAHA.116.026793","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and valvular heart disease other than significant mitral stenosis and mechanical valves: a meta-analysis","volume":"135","author":"Siontis","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib720","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2020.06.014","article-title":"Rationale and design of PROACT Xa: a randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve","volume":"227","author":"Jawitz","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib721","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cjca.2018.01.001","article-title":"Elevated incidence of atrial fibrillation and stroke in patients with atrial flutter-a population-based study","volume":"34","author":"Gula","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib722","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1460-9592.2003.00042.x","article-title":"Thromboembolic risk of patients referred for radiofrequency catheter ablation of typical atrial flutter without prior appropriate anticoagulation therapy","volume":"26","author":"Gronefeld","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib723","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1136\/heartjnl-2015-307550","article-title":"Atrial flutter and thromboembolic risk: a systematic review","volume":"101","author":"Vadmann","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib724","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0735-1097(02)02052-1","article-title":"Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion","volume":"40","author":"Gallagher","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib725","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCEP.109.871665","article-title":"Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis","volume":"2","author":"P\u00e9rez","year":"2009","journal-title":"Circ Arrhyth Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib726","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib727","first-page":"682","article-title":"Incidence of atrial fibrillation after atrial flutter ablation","volume":"2","author":"Maskoun","year":"2016","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib728","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib729","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib730","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5812\/cardiovascmed.9061","article-title":"Predictors of the atrial fibrillation following catheter ablation of typical atrial flutter","volume":"2","author":"Haghjoo","year":"2013","journal-title":"Res Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib731","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1540-8167.2007.00885.x","article-title":"Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: left-atrial size as an independent predictor of atrial fibrillation recurrence","volume":"18","author":"Ellis","year":"2007","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib732","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/clc.22538","article-title":"Stroke and systemic embolism after successful ablation of typical atrial flutter","volume":"39","author":"Exposito","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib733","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijcard.2021.02.057","article-title":"Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: a nation-wide Danish cohort study","volume":"333","author":"Giehm-Reese","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib734","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/S0735-1097(00)00982-7","article-title":"Incidence and predictors of atrial flutter in the general population","volume":"36","author":"Granada","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib735","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5603\/CJ.a2015.0052","article-title":"Left atrial and left atrial appendage functional recovery after cardioversion in patients with recent atrial fibrillation: serial echocardiographic study","volume":"22","author":"Ammar","year":"2015","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacc.2023.08.017_bib736","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0735-1097(96)00551-7","article-title":"Left atrial appendage \"stunning\" after electrical cardioversion of atrial flutter: an attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events","volume":"29","author":"Grimm","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib737","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0735-1097(03)00496-0","article-title":"Time course for resolution of left atrial appendage stunning after catheter ablation of chronic atrial flutter","volume":"41","author":"Takami","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib738","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.amjcard.2009.04.040","article-title":"Meta-analysis of ablation of atrial flutter and supraventricular tachycardia","volume":"104","author":"Spector","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib739","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/europace\/euw343","article-title":"Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for atrial flutter","volume":"19","author":"Celikyurt","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib740","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.hrthm.2014.06.038","article-title":"Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter","volume":"11","author":"Voight","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib741","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.hrthm.2015.04.008","article-title":"HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter","volume":"12","author":"Chen","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib742","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10840-016-0211-9","article-title":"Atrial fibrillation inducibility during cavotricuspid isthmus-dependent atrial flutter ablation as a predictor of clinical atrial fibrillation. A meta-analysis","volume":"48","author":"Romero","year":"2017","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib743","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.hrthm.2014.06.032","article-title":"Prognostic value of atrial fibrillation inducibility after right atrial flutter ablation","volume":"11","author":"Joza","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib744","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/jce.13040","article-title":"Interatrial conduction time can predict new-onset atrial fibrillation after radiofrequency ablation of isolated, typical atrial flutter","volume":"27","author":"Henmi","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib745","first-page":"417","article-title":"Influence of PACE score and conduction disturbances in the incidence of early new onset atrial fibrillation after typical atrial flutter ablation","volume":"79","author":"Valles","year":"2022","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib746","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00392-014-0682-6","article-title":"Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter","volume":"103","author":"Seara","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib747","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A\u00a0comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib748","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib749","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7326\/M13-1467","article-title":"Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review","volume":"160","author":"Al-Khatib","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib750","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001606","article-title":"Heart rate and adverse outcomes in patients with prevalent atrial fibrillation","volume":"8","author":"Moschovitis","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib751","article-title":"Clinical implications of heart rate control in heart failure with atrial fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry)","volume":"9","author":"Song","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib752","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.126.2.476","article-title":"Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study","volume":"126","author":"Opolski","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib753","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jacc.2011.06.055","article-title":"The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study","volume":"58","author":"Groenveld","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib754","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacc.2012.11.038","article-title":"Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation)","volume":"61","author":"Groenveld","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib755","article-title":"Increased heart rate is associated with higher mortality in patients with atrial fibrillation (AF): results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)","volume":"4","author":"Steinberg","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib756","first-page":"44","article-title":"Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation","volume":"5","author":"Pandey","year":"2017","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.08.017_bib757","first-page":"213","article-title":"Is heart rate important for patients with heart failure in atrial fibrillation?","volume":"2","author":"Cullington","year":"2014","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.08.017_bib758","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/CIRCHEARTFAILURE.115.002285","article-title":"Prognostic significance of resting heart rate and use of beta-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry","volume":"8","author":"Li","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib759","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/clc.22725","article-title":"Heart rate and outcome in heart failure with reduced ejection fraction: differences between atrial fibrillation and sinus rhythm-a CIBIS II analysis","volume":"40","author":"Mulder","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib760","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.1389","article-title":"Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction","volume":"21","author":"Sartipy","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib761","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.amjcard.2019.12.025","article-title":"Strict versus lenient versus poor rate control among patients with atrial fibrillation and heart failure (from the Get With The Guidelines - Heart Failure Program)","volume":"125","author":"Hess","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib762","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ejhf.1682","article-title":"Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction","volume":"22","author":"Docherty","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib763","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib764","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib765","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.CIR.0000135472.28234.CC","article-title":"Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia","volume":"110","author":"Nerheim","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib766","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1540-8159.2011.03124.x","article-title":"Prognostic significance of atrial arrhythmias in a primary prevention ICD population","volume":"34","author":"van Gelder","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib767","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/eurjhf\/hfr046","article-title":"Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy","volume":"13","author":"Boriani","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib768","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ahj.2007.04.001","article-title":"Rate control in patients with pacemaker affected by brady-tachy form of sick sinus syndrome","volume":"154","author":"Boriani","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib769","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjcard.2012.09.020","article-title":"Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation","volume":"111","author":"Ulimoen","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib770","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/pgmj.2008.068908","article-title":"Chronic atrial fibrillation: a systematic review of medical heart rate control management","volume":"85","author":"Nikolaidou","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacc.2023.08.017_bib771","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9149(89)90141-0","article-title":"Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter","volume":"63","author":"Platia","year":"1989","journal-title":"Am J Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2023.08.017_bib772","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000047278","article-title":"Calcium channel blockers in heart failure","volume":"89","author":"Elkayam","year":"1998","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2023.08.017_bib773","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajem.2021.08.082","article-title":"Intravenous diltiazem versus metoprolol for atrial fibrillation with rapid ventricular rate: a meta-analysis","volume":"51","author":"Lan","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib774","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jemermed.2015.01.014","article-title":"Diltiazem vs. metoprolol in the management of atrial fibrillation or flutter with rapid ventricular rate in the emergency department","volume":"49","author":"Fromm","year":"2015","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib775","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/oxfordjournals.eurheartj.a015311","article-title":"Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group","volume":"18","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib776","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1097\/CCM.0b013e3181a02f56","article-title":"Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation","volume":"37","author":"Siu","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib777","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0196-0644(97)70319-6","article-title":"Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin","volume":"29","author":"Schreck","year":"1997","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib778","first-page":"e29","article-title":"Intravenous amiodarone versus digoxin in atrial fibrillation rate control; a clinical trial","volume":"5","author":"Shojaee","year":"2017","journal-title":"Emergency"},{"key":"10.1016\/j.jacc.2023.08.017_bib779","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1378\/chest.119.2.502","article-title":"Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem alone","volume":"119","author":"Wattanasuwan","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib780","first-page":"375","article-title":"Intravenous magnesium in the management of rapid atrial fibrillation: a systematic review and meta-analysis","volume":"78","author":"Ramesh","year":"2021","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib781","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/hrt.2006.111492","article-title":"Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis","volume":"93","author":"Ho","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib782","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0002-9149(97)00962-4","article-title":"Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias","volume":"81","author":"Clemo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib783","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","article-title":"Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias","volume":"29","author":"Delle Karth","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib784","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40261-018-0631-7","article-title":"Safety of intravenous diltiazem in reduced ejection fraction heart failure with rapid atrial fibrillation","volume":"38","author":"Jandali","year":"2018","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jacc.2023.08.017_bib785","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajem.2022.03.058","article-title":"Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department","volume":"58","author":"Hasbrouck","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib786","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0735-1097(86)80157-7","article-title":"Effects of magnesium sulfate on cardiac conduction and refractoriness in humans","volume":"7","author":"DiCarlo","year":"1986","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib787","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/acem.12091","article-title":"Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness","volume":"20","author":"Scheuermeyer","year":"2013","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib788","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/1074248420987451","article-title":"A\u00a0comparison of rate control agents for the treatment of atrial fibrillation: follow-up investigation of the AFFIRM study","volume":"26","author":"Zaman","year":"2021","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib789","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jacc.2017.12.060","article-title":"Digoxin and mortality in patients with atrial fibrillation","volume":"71","author":"Lopes","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib790","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib791","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacc.2005.02.091","article-title":"Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis","volume":"46","author":"Adams","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib792","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjcard.2007.02.099","article-title":"Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure","volume":"100","author":"Ahmed","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib793","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"Khand","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib794","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.2020.23138","article-title":"Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial","volume":"324","author":"Kotecha","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib795","doi-asserted-by":"crossref","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib796","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib797","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction","volume":"319","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib798","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib799","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjcard.2012.09.020","article-title":"Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation","volume":"111","author":"Ulimoen","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib800","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/pgmj.2008.068908","article-title":"Chronic atrial fibrillation: a systematic review of medical heart rate control management","volume":"85","author":"Nikolaidou","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacc.2023.08.017_bib801","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJM196911272812203","article-title":"Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay","volume":"281","author":"Smith","year":"1969","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib802","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1001\/jamainternmed.2013.7756","article-title":"Reference laboratory values for digoxin following publication of Digitalis Investigation Group (DIG) trial data","volume":"173","author":"Hauptman","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib803","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.amjcard.2012.02.028","article-title":"Therapeutic ranges of serum digoxin concentrations in patients with heart failure","volume":"109","author":"Goldberger","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib804","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib805","first-page":"345","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"28","author":"Hohnloser","year":"2009","journal-title":"Revista Portuguesa de Cardiologia"},{"key":"10.1016\/j.jacc.2023.08.017_bib806","doi-asserted-by":"crossref","first-page":"527.e521","DOI":"10.1016\/j.ahj.2008.06.010","article-title":"Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib807","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1540-8159.1997.tb06179.x","article-title":"Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction","volume":"20","author":"Geelen","year":"1997","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib808","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.hrthm.2013.01.021","article-title":"Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation","volume":"10","author":"Wang","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib809","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/01.CIR.98.10.953","article-title":"Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study","volume":"98","author":"Brignole","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib810","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/europace\/eum091","article-title":"Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial","volume":"9","author":"Lim","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib811","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.CIR.101.10.1138","article-title":"Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis","volume":"101","author":"Wood","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib812","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.hrthm.2006.10.016","article-title":"Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials","volume":"4","author":"Bradley","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib813","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.hrthm.2011.12.014","article-title":"Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study","volume":"9","author":"Udo","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib814","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1540-8159.2011.03240.x","article-title":"Are elderly patients at increased risk of complications following pacemaker implantation? A meta-analysis of randomized trials","volume":"35","author":"Armaganijan","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib815","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2022.06.058","article-title":"Atrioventricular node ablation and pacing for atrial tachyarrhythmias: a meta-analysis of postoperative outcomes","volume":"363","author":"Baudo","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib816","doi-asserted-by":"crossref","first-page":"iv10","DOI":"10.1093\/europace\/eux263","article-title":"Atrioventricular node ablation and His bundle pacing","volume":"19","author":"Vijayaraman","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib817","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/pace.14252","article-title":"Effectiveness and safety of AV node ablation after His bundle pacing in patients with uncontrolled atrial arrhythmias","volume":"44","author":"Mori\u00f1a-V\u00e1zquez","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib818","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.hrthm.2022.03.1222","article-title":"Atrioventricular junction ablation in patients with conduction system pacing leads: a comparison of His-bundle vs left bundle branch area pacing leads","volume":"19","author":"Pillai","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib819","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.hroo.2022.04.005","article-title":"Conduction system pacing versus conventional pacing in patients undergoing atrioventricular node ablation: nonrandomized, on-treatment comparison","volume":"3","author":"Vijayaraman","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2023.08.017_bib820","first-page":"49","article-title":"Atrioventricular junction ablation and pacemaker therapy versus drug treatment in atrial fibrillation","volume":"15","author":"Brignole","year":"1998","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib821","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.102.7.736","article-title":"Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation","volume":"102","author":"Gillis","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib822","first-page":"S406","article-title":"Survival of dual chamber pacing post atrioventricular nodal ablation in patients with atrial fibrillation","volume":"6","author":"D","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib823","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/euhj.2001.2971","article-title":"An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation","volume":"23","author":"Brignole","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib824","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1460-9592.2002.00291.x","article-title":"Transient proarrhythmic state following atrioventricular junctional radiofrequency ablation","volume":"25","author":"Nowinski","year":"2002","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib825","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1161\/CIR.0000000000000629","volume":"140","author":"Slotwiner","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib826","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0735-1097(93)90084-E","article-title":"Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction","volume":"21","author":"Olgin","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib827","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1009795330454","article-title":"The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators","volume":"2","author":"Kay","year":"1998","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib828","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0735-1097(03)00338-3","article-title":"The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT)","volume":"41","author":"Weerasooriya","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib829","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4065\/75.8.790","article-title":"Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation","volume":"75","author":"Redfield","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.08.017_bib830","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.hrthm.2022.02.014","article-title":"Simultaneous conduction system pacing and atrioventricular node ablation via axillary vs femoral access","volume":"19","author":"Vijayaraman","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib831","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/europace\/eut345","article-title":"Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey","volume":"15","author":"Bongiorni","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib832","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.amjcard.2005.11.044","article-title":"Ventricular remodeling during long-term right ventricular pacing following His bundle ablation","volume":"97","author":"Vernooy","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib833","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1540-8167.2005.50062.x","article-title":"Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study)","volume":"16","author":"Doshi","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib834","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1540-8167.2007.00994.x","article-title":"Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation","volume":"19","author":"Chen","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib835","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib836","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMoa041018","article-title":"Catheter ablation for atrial fibrillation in congestive heart failure","volume":"351","author":"Hsu","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib837","first-page":"999","article-title":"Regression of diffuse ventricular fibrosis following restoration of sinus rhythm with catheter ablation in patients with atrial fibrillation and systolic dysfunction: a substudy of the CAMERA MRI trial","volume":"4","author":"Prabhu","year":"2018","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib838","first-page":"1411","article-title":"Tachycardiomyopathy in patients without underlying structural heart disease","volume":"8","author":"Stronati","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib839","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/clc.20161","article-title":"Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy","volume":"31","author":"Jeong","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib840","first-page":"101","article-title":"Factors associated with left ventricular function recovery in patients with atrial fibrillation related cardiomyopathy","volume":"24","author":"Marcusohn","year":"2022","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jacc.2023.08.017_bib841","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.amjcard.2004.01.069","article-title":"Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study)","volume":"93","author":"Cooper","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib842","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2020.01.011","article-title":"Treatment strategies and subsequent changes in the patient-reported quality-of-life among elderly patients with atrial fibrillation","volume":"222","author":"Miura","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib843","first-page":"658","article-title":"Functional status with rhythm- versus rate-control strategy for persistent atrial fibrillation","volume":"128","author":"Kosior","year":"2018","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib844","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib845","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib846","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib847","doi-asserted-by":"crossref","first-page":"n991","DOI":"10.1136\/bmj.n991","article-title":"Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study","volume":"373","author":"Kim","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib848","first-page":"1","article-title":"Generalizability of the EAST-AFNET 4 Trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation","volume":"11","author":"Dickow","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib849","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib850","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib851","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib852","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib853","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib854","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10840-015-0029-x","article-title":"The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease?","volume":"44","author":"Veasey","year":"2015","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib855","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/heartjnl-2014-307043","article-title":"Heart rate is associated with progression of atrial fibrillation, independent of rhythm","volume":"101","author":"Holmqvist","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib856","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjcard.2013.02.056","article-title":"Predictors of progression of recently diagnosed atrial fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)-United States cohort","volume":"112","author":"Zhang","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib857","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2012.02.015","article-title":"Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy","volume":"163","author":"De Vos","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib858","article-title":"Incidence and predictors of atrial fibrillation progression","volume":"8","author":"Blum","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib859","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib860","first-page":"384","article-title":"Rate control drugs differ in the prevention of progression of atrial fibrillation","volume":"24","author":"Koldenhof","year":"2022","journal-title":"EP: Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib861","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jce.14826","article-title":"Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: a report from the Chinese Atrial Fibrillation Registry study","volume":"32","author":"Yang","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib862","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/CIRCULATIONAHA.116.024926","article-title":"Should we perform catheter ablation for asymptomatic atrial fibrillation?","volume":"136","author":"Kalman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib863","first-page":"3979","article-title":"Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: a systematic review and meta-analysis of 81,462 patients","volume":"10","author":"Sgreccia","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib864","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib865","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijcard.2015.03.122","article-title":"Asymptomatic\" persistent or permanent atrial fibrillation: a misnomer in selected patients","volume":"185","author":"Ganapathy","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib866","article-title":"Clinical utility of rhythm control by electrical cardioversion to assess the association between self-reported symptoms and rhythm status in patients with persistent atrial fibrillation","volume":"36","author":"Hermans","year":"2021","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacc.2023.08.017_bib867","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1253\/circj.CJ-13-1272","article-title":"Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation","volume":"78","author":"Senoo","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2023.08.017_bib868","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ahj.2011.05.008","article-title":"Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial","volume":"162","author":"Disertori","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib869","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10840-022-01196-y","article-title":"Impact of catheter ablation versus medical therapy on cognitive function in atrial fibrillation: a systematic review","volume":"65","author":"Bodagh","year":"2022","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ageing\/afab248","article-title":"Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study","volume":"51","author":"Kim","year":"2022","journal-title":"Age Ageing"},{"key":"10.1016\/j.jacc.2023.08.017_bib871","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1540-8167.2011.02035.x","article-title":"Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation","volume":"22","author":"Bunch","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib872","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2019.10.005","article-title":"Impact of initial heart failure emergence on clinical outcomes of atrial fibrillation patients in the AFFIRM trial","volume":"220","author":"Slee","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib873","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jacc.2011.06.032","article-title":"Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control","volume":"58","author":"Gertz","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib874","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10840-013-9784-8","article-title":"Mitral regurgitation recovery and atrial reverse remodeling following pulmonary vein isolation procedure in patients with atrial fibrillation: a clinical observation proof-of-concept cardiac MRI study","volume":"37","author":"Reddy","year":"2013","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib875","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ccl.2021.01.010","article-title":"Looking into the mechanistic link between mitral regurgitation and atrial fibrillation","volume":"39","author":"Abe","year":"2021","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jacc.2023.08.017_bib876","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2021.12.029","article-title":"Restoring sinus rhythm reverses cardiac remodeling and reduces valvular regurgitation in patients with atrial fibrillation","volume":"79","author":"Soulat-Dufour","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib877","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1111\/jce.14707","article-title":"Improvement in tricuspid regurgitation following catheter ablation of atrial fibrillation","volume":"31","author":"Markman","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib878","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/00015385.2019.1649339","article-title":"Long-term effect of atrial fibrillation on the evolution of mitral and tricuspid valve regurgitation","volume":"75","author":"Pype","year":"2020","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib879","article-title":"Impact of Surgical ablation of atrial fibrillation on the progression of tricuspid regurgitation and right-sided heart remodeling after mitral-valve surgery: a propensity-score matching analysis","volume":"5","author":"Wang","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib880","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/jce.13824","article-title":"Relations between baseline burden, maximum duration, and relative reduction of atrial fibrillation: insights from continuous monitoring in rhythm control","volume":"30","author":"Lin","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib881","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hroo.2021.11.012","article-title":"Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablation","volume":"3","author":"Chew","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2023.08.017_bib882","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib883","doi-asserted-by":"crossref","DOI":"10.1161\/HAE.0000000000000078","article-title":"Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association","volume":"14","author":"Gopinathannair","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib884","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jacc.2003.08.037","article-title":"Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study","volume":"43","author":"Hagens","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib885","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/HCQ.0000000000000011","volume":"7","author":"Ha","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib886","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cjco.2022.03.001","article-title":"Rhythm control vs rate control in a contemporary ambulatory atrial fibrillation cohort: post hoc analysis of the IMPACT-AF trial","volume":"4","author":"Govindapillai","year":"2022","journal-title":"CJC Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib887","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jce.12930","article-title":"Comparison of radiofrequency catheter ablation between asymptomatic and symptomatic persistent atrial fibrillation: a propensity score matched analysis","volume":"27","author":"Wu","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib888","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/jce.12467","article-title":"Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival","volume":"25","author":"Mohanty","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib889","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2012.10.031","article-title":"Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure","volume":"61","author":"Suman-Horduna","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib890","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMoa041018","article-title":"Catheter ablation for atrial fibrillation in congestive heart failure","volume":"351","author":"Hsu","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib891","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","article-title":"Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial","volume":"145","author":"Parkash","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib892","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1038\/s41598-022-07466-z","article-title":"Rhythm control without catheter ablation may have benefits beyond stroke prevention in rivaroxaban-treated non-permanent atrial fibrillation","volume":"12","author":"Chiou","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib893","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib894","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijcard.2014.01.099","article-title":"Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study","volume":"172","author":"Crijns","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib895","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/europace\/eut143","article-title":"Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey","volume":"15","author":"Hern\u00e1ndez-Madrid","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib896","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/europace\/eur406","article-title":"Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey","volume":"14","author":"Pisters","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib897","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2010.07.005","article-title":"Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments","volume":"57","author":"Stiell","year":"2011","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib898","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000151703","article-title":"Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management","volume":"112","author":"Dankner","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2023.08.017_bib899","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/europace\/euaa057","article-title":"Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure","volume":"22","author":"Brandes","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib900","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.amjcard.2013.10.036","article-title":"Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study)","volume":"113","author":"Lip","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib901","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib902","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib903","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0735-1097(94)90412-X","article-title":"Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for \"atrial stunning\" as a mechanism of thromboembolic complications","volume":"23","author":"Fatkin","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib904","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0735-1097(93)90543-A","article-title":"Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography","volume":"22","author":"Grimm","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib905","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0735-1097(89)90602-5","article-title":"Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation","volume":"13","author":"Manning","year":"1989","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib906","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/0735-1097(94)90652-1","article-title":"Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation","volume":"23","author":"Manning","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib907","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0002-9149(98)00704-8","article-title":"Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis","volume":"82","author":"Berger","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib908","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1093\/eurheartj\/ehz521","article-title":"Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials","volume":"40","author":"McIntyre","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib909","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2016.05.007","article-title":"Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"178","author":"Lip","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib910","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.hrthm.2015.03.028","article-title":"Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization","volume":"12","author":"Aryana","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib911","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.hrthm.2019.08.003","article-title":"Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: long-term results of a multicenter study","volume":"17","author":"Mohanty","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib912","first-page":"766","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib913","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jacc.2011.11.028","volume":"59","author":"Viles-Gonzalez","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib914","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib915","first-page":"15","article-title":"Temporal changes and clinical implications of delayed peridevice leak following left atrial appendage closure","volume":"8","author":"Afzal","year":"2022","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib916","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib917","first-page":"1629","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib918","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCULATIONAHA.118.035090","article-title":"Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes","volume":"138","author":"Dukkipati","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib919","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacc.2021.04.098","article-title":"Predictors of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"78","author":"Simard","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib920","first-page":"1380","article-title":"Incidence, characteristics, and clinical course of device-related thrombus after Watchman left atrial appendage occlusion device implantation in atrial fibrillation patients","volume":"3","author":"Kubo","year":"2017","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib921","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2019.08.1045","article-title":"Direct current cardioversion of atrial fibrillation in patients with left atrial appendage occlusion devices","volume":"74","author":"Sharma","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib922","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jama.2014.3824","article-title":"Time to cardioversion for acute atrial fibrillation and thromboembolic complications","volume":"312","author":"Nuotio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib923","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.amjcard.2016.01.024","article-title":"Anticoagulation, CHA2DS2VASc score, and thromboembolic risk of cardioversion of acute atrial fibrillation (from the FinCV study)","volume":"117","author":"Gr\u00f6nberg","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib924","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.amjcard.2013.10.036","article-title":"Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study)","volume":"113","author":"Lip","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib925","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib926","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/pgmj.71.838.457","article-title":"Cardioversion of atrial fibrillation","volume":"71","author":"Lip","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacc.2023.08.017_bib927","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehu367","article-title":"Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation","volume":"35","author":"Cappato","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib928","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehy148","article-title":"Apixaban compared to heparin\/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial","volume":"39","author":"Ezekowitz","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib929","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0140-6736(16)31474-X","article-title":"Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial","volume":"388","author":"Goette","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib930","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jacc.2018.07.083","article-title":"Direct oral anticoagulants halve thromboembolic events after cardioversion of AF compared with warfarin","volume":"72","author":"Kotecha","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib931","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/hrt.29.4.469","article-title":"Electrical reversion of cardiac arrhythmias","volume":"29","author":"Lown","year":"1967","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib932","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-8703(80)90071-X","article-title":"Cardioversion and defibrillation","volume":"100","author":"DeSilva","year":"1980","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib933","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00330-020-07172-2","article-title":"Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation: delayed contrast-enhanced cardiac CT","volume":"31","author":"Spagnolo","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib934","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCIMAGING.112.000153","article-title":"Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis","volume":"6","author":"Romero","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2023.08.017_bib935","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jcmg.2017.12.019","article-title":"Roles of transesophageal echocardiography and cardiac computed tomography for evaluation of left atrial thrombus and associated pathology: a review and critical analysis","volume":"11","author":"Pathan","year":"2018","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2023.08.017_bib936","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.89.6.2509","article-title":"Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study","volume":"89","author":"Black","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib937","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0735-1097(97)00455-5","article-title":"Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?","volume":"31","author":"Tieleman","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib938","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0735-1097(97)00173-3","article-title":"Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation","volume":"30","author":"Harjai","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib939","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ehjci\/jeab213","article-title":"The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics","volume":"23","author":"Spartera","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2023.08.017_bib940","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008112","article-title":"Detection of device-related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography","volume":"12","author":"Korsholm","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2023.08.017_bib941","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/jce.13289","article-title":"Long-term follow-up after left atrial appendage occlusion with comparison of transesophageal echocardiography versus computed tomography to guide medical therapy and data about postclosure cardioversion","volume":"28","author":"Berte","year":"2017","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib942","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/ehjci\/jev067","article-title":"Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure","volume":"16","author":"Saw","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2023.08.017_bib943","first-page":"487","article-title":"Incidence of thromboembolic complications within 30 days of electrical cardioversion performed within 48 hours of atrial fibrillation onset","volume":"2","author":"Garg","year":"2016","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib944","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s43678-021-00103-0","article-title":"Thromboembolic events following cardioversion of acute atrial fibrillation and flutter: a systematic review and meta-analysis","volume":"23","author":"Wong","year":"2021","journal-title":"CJEM"},{"key":"10.1016\/j.jacc.2023.08.017_bib945","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000151703","article-title":"Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management","volume":"112","author":"Dankner","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2023.08.017_bib946","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(19)32994-0","article-title":"Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial","volume":"395","author":"Stiell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib947","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/hrt.29.4.469","article-title":"Electrical reversion of cardiac arrhythmias","volume":"29","author":"Lown","year":"1967","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib948","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.101.11.1282","article-title":"Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks","volume":"101","author":"Mittal","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib949","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/eurheartj\/ehz585","article-title":"Maximum-fixed energy shocks for cardioverting atrial fibrillation","volume":"41","author":"Schmidt","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib950","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijcard.2014.01.099","article-title":"Contemporary real life cardioversion of atrial fibrillation: results from the multinational RHYTHM-AF study","volume":"172","author":"Crijns","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib951","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(02)11315-8","article-title":"Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial","volume":"360","author":"Kirchhof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib952","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/europace\/euy310","article-title":"Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis","volume":"21","author":"Um","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib953","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199906173402401","article-title":"Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment","volume":"340","author":"Oral","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib954","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jce.13786","article-title":"Cardioversion of atrial fibrillation in obese patients: results from the Cardioversion-BMI randomized controlled trial","volume":"30","author":"Voskoboinik","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib955","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2010.07.005","article-title":"Variation in management of recent-onset atrial fibrillation and flutter among academic hospital emergency departments","volume":"57","author":"Stiell","year":"2011","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib956","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib957","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/europace\/eut143","article-title":"Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey","volume":"15","author":"Hernandez-Madrid","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib958","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/europace\/eur406","article-title":"Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey","volume":"14","author":"Pisters","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib959","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.annemergmed.2004.02.016","article-title":"Electrical cardioversion of emergency department patients with atrial fibrillation","volume":"44","author":"Burton","year":"2004","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib960","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/emj.2009.083196","article-title":"Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment","volume":"28","author":"Cristoni","year":"2011","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jacc.2023.08.017_bib961","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jemermed.2004.07.011","article-title":"Synchronized emergency department cardioversion of atrial dysrhythmias saves time, money and resources","volume":"28","author":"Jacoby","year":"2005","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib962","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/emj.2004.021055","article-title":"Biphasic cardioversion of acute atrial fibrillation in the emergency department","volume":"23","author":"Lo","year":"2006","journal-title":"Emerg Med J"},{"key":"10.1016\/j.jacc.2023.08.017_bib963","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/europace\/euaa057","article-title":"Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure","volume":"22","author":"Brandes","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib964","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/europace\/eut106","article-title":"Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study","volume":"15","author":"Gronberg","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib965","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1067\/mhj.2003.112","article-title":"Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costs","volume":"145","author":"Botkin","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib966","first-page":"CD010824","article-title":"Anaesthetic and sedative agents used for electrical cardioversion","volume":"3","author":"Lewis","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib967","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0002-9149(94)90504-5","article-title":"Electrical cardioversion resulting in death from synchronization failure","volume":"74","author":"Ebrahimi","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib968","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jccase.2020.08.014","article-title":"Iatrogenic ventricular fibrillation caused by inappropriately synchronized cardioversion in a patient with pre-excited atrial fibrillation: a case report","volume":"23","author":"Ikeda","year":"2021","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.jacc.2023.08.017_bib969","doi-asserted-by":"crossref","first-page":"39","DOI":"10.14503\/THIJ-16-6162","article-title":"Iatrogenic ventricular fibrillation after direct-current cardioversion of preexcited atrial fibrillation caused by inadvertent T-wave synchronization","volume":"45","author":"Kaufmann","year":"2018","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.jacc.2023.08.017_bib970","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.hrthm.2020.11.005","article-title":"Active compression versus standard anterior-posterior defibrillation for external cardioversion of atrial fibrillation: a prospective randomized study","volume":"18","author":"Squara","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib971","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.CIR.86.5.1415","article-title":"A\u00a0randomized comparison of external and internal cardioversion of chronic atrial fibrillation","volume":"86","author":"L\u00e9vy","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib972","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000151703","article-title":"Treatment of stable atrial fibrillation in the emergency department: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management","volume":"112","author":"Dankner","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2023.08.017_bib973","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib974","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib975","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.eurheartj.a060945","article-title":"Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study","volume":"16","author":"Hou","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib976","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1111\/j.1540-8159.1998.tb01204.x","article-title":"Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study","volume":"21","author":"Kochiadakis","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib977","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1053\/euhj.1999.1747","article-title":"Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study","volume":"20","author":"Cotter","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib978","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1378\/chest.117.6.1538","article-title":"Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study","volume":"117","author":"Vardas","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib979","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0735-1097(02)02705-5","article-title":"Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis","volume":"41","author":"Chevalier","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib980","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9149(92)91392-H","article-title":"Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension","volume":"70","author":"Capucci","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib981","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0002-9149(94)90915-6","article-title":"Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide","volume":"74","author":"Capucci","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib982","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/europace\/euab014","article-title":"Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials","volume":"23","author":"Ibrahim","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib983","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-5273(96)02841-0","article-title":"Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens","volume":"58","author":"Botto","year":"1997","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib984","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-126-8-199704150-00006","article-title":"Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease: a randomized, controlled trial","volume":"126","author":"Boriani","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib985","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/oxfordjournals.eurheartj.a015146","article-title":"Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study","volume":"18","author":"Azpitarte","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib986","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-5273(01)00459-4","article-title":"Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias","volume":"80","author":"Brembilla-Perrot","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib987","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \"pill-in-the-pocket\" approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib988","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/hrt.2009.187963","article-title":"Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment","volume":"96","author":"Alboni","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib989","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hrthm.2017.10.002","article-title":"Clinical effectiveness of a systematic \"pill-in-the-pocket\" approach for the management of paroxysmal atrial fibrillation","volume":"15","author":"Andrade","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib990","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1007714203984","article-title":"Conversion of atrial fibrillation to sinus rhythm using acute intravenous procainamide infusion","volume":"12","author":"Kochiadakis","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib991","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199906173402401","article-title":"Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment","volume":"340","author":"Oral","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib992","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9149(96)00566-8","article-title":"Safety and risk\/benefit analysis of ibutilide for acute conversion of atrial fibrillation\/flutter","volume":"78","author":"Kowey","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib993","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0735-1097(98)00078-3","article-title":"Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation","volume":"31","author":"Volgman","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib994","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1161\/01.CIR.96.12.4298","article-title":"Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy","volume":"96","author":"Stambler","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib995","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib996","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy","volume":"104","author":"Pedersen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib997","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib998","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib999","doi-asserted-by":"crossref","first-page":"863.e861","DOI":"10.1016\/j.ahj.2005.09.009","article-title":"A\u00a0randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned","volume":"151","author":"Vijayalakshmi","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1000","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0002-8703(95)90324-0","article-title":"Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group","volume":"129","author":"Sung","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1001","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/hrt.79.6.568","article-title":"Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation","volume":"79","author":"Vos","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1002","doi-asserted-by":"crossref","first-page":"147r","DOI":"10.1016\/S0002-9149(99)00715-8","article-title":"Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation","volume":"84","author":"Van Gelder","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1003","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1592\/phco.23.3.296.32109","article-title":"Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide","volume":"23","author":"Caron","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2023.08.017_bib1004","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/ajhp\/60.22.2308","article-title":"Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter","volume":"60","author":"Kalus","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1005","first-page":"1515","article-title":"Safety of pill-in-the-pocket class 1C antiarrhythmic drugs for atrial fibrillation","volume":"8","author":"Markman","year":"2022","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1006","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) substudy","volume":"104","author":"Pedersen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1007","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/01.CIR.98.23.2574","volume":"98","author":"Deedwania","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1008","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.80.6.1557","volume":"80","author":"Anderson","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1009","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(12)60570-4","article-title":"Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial","volume":"380","author":"Kirchhof","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib1010","first-page":"Cd005049","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"9","author":"Valembois","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib1011","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-9149(93)90511-A","article-title":"Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation","volume":"71","author":"Reimold","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1012","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0002-9149(01)01806-9","article-title":"Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation","volume":"88","author":"Bellandi","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1013","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0002-9149(03)00974-3","article-title":"Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation","volume":"92","author":"Pritchett","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1014","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2143\/AC.59.3.2005179","article-title":"Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study","volume":"59","author":"Dogan","year":"2004","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1015","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.amjcard.2004.08.041","article-title":"Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation","volume":"94","author":"Kochiadakis","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1016","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0002-9149(02)02867-9","article-title":"Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol\/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study)","volume":"90","author":"Meinertz","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1017","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-5273(01)00459-4","article-title":"Predictors of atrial flutter with 1:1 conduction in patients treated with class I antiarrhythmic drugs for atrial tachyarrhythmias","volume":"80","author":"Brembilla-Perrot","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1018","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0195-668X(03)00321-X","article-title":"Dronedarone for prevention of atrial fibrillation: a dose-ranging study","volume":"24","author":"Touboul","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1019","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa054686","article-title":"Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter","volume":"357","author":"Singh","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1021","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1022","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1023","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/heart.84.3.251","article-title":"Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study","volume":"84","author":"Kochiadakis","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1024","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators","volume":"342","author":"Roy","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/107424840100600403","article-title":"Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: a prospective, multicenter, randomized, controlled, double blind trial","volume":"6","author":"Galperin","year":"2001","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib1026","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0735-1097(03)00559-X","article-title":"Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug","volume":"42","author":"Greene","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1027","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1540-8167.2010.01764.x","article-title":"A\u00a0short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study","volume":"21","author":"Le Heuzey","year":"2010","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1028","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.amjmed.2015.08.039","article-title":"Practical management guide for clinicians who treat patients with amiodarone","volume":"129","author":"Epstein","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1029","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40256-020-00401-5","article-title":"Amiodarone: a comprehensive guide for clinicians","volume":"20","author":"Hamilton","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2023.08.017_bib1030","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1031","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1032","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1033","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1034","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/CIRCEP.114.002339","article-title":"Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter","volume":"8","author":"Abraham","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005333","article-title":"Safety of oral dofetilide reloading for treatment of atrial arrhythmias","volume":"10","author":"Cho","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1036","article-title":"Drug interactions affecting antiarrhythmic drug use","volume":"15","author":"Mar","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1037","first-page":"555","article-title":"Feasibility and safety of intravenous sotalol loading in adult patients with atrial fibrillation (DASH-AF)","volume":"9","author":"Lakkireddy","year":"2023","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1038","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction","volume":"327","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1039","doi-asserted-by":"crossref","first-page":"109f","DOI":"10.1016\/0002-9149(93)90973-G","article-title":"Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators","volume":"72","author":"Siebels","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1040","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1041","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/CIRCEP.114.002339","article-title":"Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter","volume":"8","author":"Abraham","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1042","first-page":"1276","article-title":"Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis","volume":"44","author":"Kaufman","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1043","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.4022\/jafib.1805","article-title":"Safety and efficacy of inpatient initiation of dofetilide versus sotalol for atrial fibrillation","volume":"10","author":"Yarlagadda","year":"2017","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1044","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.CIR.104.3.292","article-title":"Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy","volume":"104","author":"Pedersen","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1046","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(00)03402-4","article-title":"Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial","volume":"356","author":"Kober","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib1047","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0735-1097(98)00189-2","article-title":"Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications","volume":"32","author":"Chung","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1048","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \"pill-in-the-pocket\" approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1049","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hrthm.2017.10.002","article-title":"Clinical effectiveness of a systematic \"pill-in-the-pocket\" approach for the management of paroxysmal atrial fibrillation","volume":"15","author":"Andrade","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1050","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/j.1540-8159.1998.tb01203.x","article-title":"Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols","volume":"21","author":"Boriani","year":"1998","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1051","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/oxfordjournals.eurheartj.a015146","article-title":"Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study","volume":"18","author":"Azpitarte","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1052","first-page":"1515","article-title":"Safety of pill-in-the-pocket class 1C antiarrhythmic drugs for atrial fibrillation","volume":"8","author":"Markman","year":"2022","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1053","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: a scientific statement from the American Heart Association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1054","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1055","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4022\/jafib.1499","article-title":"Intravenous sotalol - reintroducing a forgotten agent to the electrophysiology therapeutic arsenal","volume":"9","author":"Batul","year":"2017","journal-title":"J\u00a0Atr Fibrillation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1056","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1210\/clinem\/dgaa686","article-title":"Evaluation and treatment of amiodarone-induced thyroid disorders","volume":"106","author":"Ylli","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2023.08.017_bib1057","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jcpt.13024","article-title":"Time-to-onset analysis of amiodarone-associated thyroid dysfunction","volume":"45","author":"Kinoshita","year":"2020","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib1058","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/j.1875-9114.1989.tb04102.x","article-title":"Hepatotoxicity associated with amiodarone therapy","volume":"9","author":"Flaharty","year":"1989","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jacc.2023.08.017_bib1059","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40256-020-00401-5","article-title":"Amiodarone: a comprehensive guide for clinicians","volume":"20","author":"Hamilton","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2023.08.017_bib1060","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hrthm.2007.07.020","article-title":"A\u00a0practical guide for clinicians who treat patients with amiodarone: 2007","volume":"4","author":"Goldschlager","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1061","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(89)90221-0","article-title":"Serial lung function testing in patients treated with amiodarone: a prospective study","volume":"86","author":"Gleadhill","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1062","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/imj.14647","article-title":"Pulmonary function testing for the early detection of drug-induced lung disease: a systematic review in adults treated with drugs associated with pulmonary toxicity","volume":"50","author":"Bui","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1063","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.amjmed.2011.09.020","article-title":"Amiodarone-associated optic neuropathy: a critical review","volume":"125","author":"Passman","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1064","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1161\/CIR.0000000000000905","article-title":"Drug-induced arrhythmias: a scientific statement from the American Heart Association","volume":"142","author":"Tisdale","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-121-7-199410010-00009","article-title":"Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia","volume":"121","author":"Hohnloser","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1066","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","article-title":"Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study","volume":"102","author":"Singh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1067","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM199909163411201","article-title":"Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group","volume":"341","author":"Torp-Pedersen","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1068","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s13104-016-2116-1","article-title":"The use of dronedarone for recurrent ventricular tachycardia: a case report and review of the literature","volume":"9","author":"Rizkallah","year":"2016","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jacc.2023.08.017_bib1069","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/15748863113089990031","article-title":"Severe toxic hepatitis associated with dronedarone","volume":"8","author":"Jahn","year":"2013","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.jacc.2023.08.017_bib1070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.100.4.369","article-title":"Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery","volume":"100","author":"VanderLugt","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1071","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","article-title":"Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study","volume":"28","author":"Ellenbogen","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1072","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0002-9149(97)00395-0","article-title":"Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function","volume":"80","author":"Stambler","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1073","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0002-8703(98)70071-7","article-title":"Suppression of inducible ventricular tachycardia by ibutilide in patients with coronary artery disease. Ibutilide Investigators","volume":"135","author":"Wood","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1074","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0002-8703(98)70010-9","article-title":"Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation","volume":"136","author":"Abi-Mansour","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1075","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00045391-200307000-00005","article-title":"Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety","volume":"10","author":"Gowda","year":"2003","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib1076","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","article-title":"Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators","volume":"94","author":"Stambler","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1077","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0735-1097(83)80226-5","article-title":"Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients","volume":"2","author":"Kay","year":"1983","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1078","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1378\/chest.117.6.1538","article-title":"Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study","volume":"117","author":"Vardas","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2023.08.017_bib1079","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/hrt.51.2.157","article-title":"Sotalol, hypokalaemia, syncope, and torsade de pointes","volume":"51","author":"McKibbin","year":"1984","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1080","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/0002-8703(86)90010-4","article-title":"Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care","volume":"111","author":"Roden","year":"1986","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1081","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.md.0000085057.63483.9b","article-title":"Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors","volume":"82","author":"Zeltser","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2023.08.017_bib1082","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0750-7658(85)80253-7","article-title":"[Torsades de pointes and hypomagnesemia]","volume":"4","author":"Marsepoil","year":"1985","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.jacc.2023.08.017_bib1083","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1586\/14779072.2013.840535","article-title":"Torsades de pointes following clarithromycin treatment","volume":"11","author":"Gysel","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib1084","article-title":"Overdrive pacing in a patient with incessant torsades de pointes","volume":"2013","author":"Overbey","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib1085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1007714203984","article-title":"Conversion of atrial fibrillation to sinus rhythm using acute intravenous procainamide infusion","volume":"12","author":"Kochiadakis","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2023.08.017_bib1086","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1161\/01.CIR.96.12.4298","article-title":"Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy","volume":"96","author":"Stambler","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1087","first-page":"6","article-title":"Procainamide induced sustained monomorphic ventricular tachycardia in a patient with benign premature ventricular complexes","volume":"2","author":"Bhandari","year":"1986","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1088","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-8703(95)90048-9","article-title":"Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group","volume":"129","author":"Singh","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1089","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJMoa041705","article-title":"Amiodarone versus sotalol for atrial fibrillation","volume":"352","author":"Singh","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1090","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ehj.2004.04.015","article-title":"Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial","volume":"25","author":"Fetsch","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1091","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ehj.2004.04.025","article-title":"Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation","volume":"25","author":"Dernellis","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1092","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1093","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1094","first-page":"985","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"151","author":"Ducharme","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1095","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ahj.2006.02.028","article-title":"Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial","volume":"151","author":"McMurray","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1096","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2004.10.068","article-title":"Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study","volume":"45","author":"Wachtell","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1097","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ahj.2006.01.007","article-title":"Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation","volume":"152","author":"Anand","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1098","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.296.10.1242","article-title":"Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension","volume":"296","author":"Okin","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1099","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction. results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1100","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jtcvs.2009.03.054","article-title":"Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review","volume":"138","author":"Liakopoulos","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1101","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ejcts\/ezt181","article-title":"Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients","volume":"45","author":"Kuhn","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1102","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.106.621763","article-title":"Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study","volume":"114","author":"Patti","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1103","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.athoracsur.2008.01.040","article-title":"Dose-related effect of statins on atrial fibrillation after cardiac surgery","volume":"85","author":"Kourliouros","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1104","first-page":"521","article-title":"Statin therapy may influence the incidence of postoperative atrial fibrillation: what is the evidence?","volume":"36","author":"Saso","year":"2009","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1105","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMoa1507750","article-title":"Perioperative rosuvastatin in cardiac surgery","volume":"374","author":"Zheng","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1106","doi-asserted-by":"crossref","first-page":"d1250","DOI":"10.1136\/bmj.d1250","article-title":"Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials","volume":"342","author":"Rahimi","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib1107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12872-017-0478-5","article-title":"Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis","volume":"17","author":"Hemil\u00e4","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2023.08.017_bib1108","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa0805710","article-title":"Valsartan for prevention of recurrent atrial fibrillation","volume":"360","author":"Delise","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1109","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJMoa1008816","article-title":"Irbesartan in patients with atrial fibrillation","volume":"364","author":"Yusuf","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.111.965178","article-title":"Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial","volume":"5","author":"Goette","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1111","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1112","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone pathway blockade to prevent atrial fibrillation: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1113","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1097\/FJC.0000000000001183","article-title":"Association of SGLT2 inhibitors with risk of atrial fibrillation and stroke in patients with and without type 2 diabetes: a systemic review and meta-analysis of randomized controlled trials","volume":"79","author":"Zheng","year":"2022","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1114","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/dom.14211","article-title":"Sodium-glucose co-transporter-2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials","volume":"23","author":"Okunrintemi","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2023.08.017_bib1115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12933-020-01105-5","article-title":"SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials","volume":"19","author":"Li","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1116","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/europace\/euq386","article-title":"N-3 Polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study","volume":"13","author":"Bianconi","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1117","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1001\/jama.2010.1735","article-title":"Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial","volume":"304","author":"Kowey","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1118","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.2012.28733","article-title":"Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial","volume":"308","author":"Mozaffarian","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1119","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2012.11.021","article-title":"Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial","volume":"61","author":"Macchia","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1120","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.121.055654","article-title":"Effect of long-term marine -3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis","volume":"144","author":"Gencer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1121","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00210-009-0468-y","article-title":"Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: Review of evidence and clinical relevance","volume":"381","author":"Savelieva","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"suppl 1","key":"10.1016\/j.jacc.2023.08.017_bib1122","first-page":"S8","article-title":"A\u00a0randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation","volume":"86","author":"Krittayaphong","year":"2003","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.jacc.2023.08.017_bib1123","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/eurheartj\/ehi583","article-title":"Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study)","volume":"27","author":"Stabile","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1124","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.jacc.2006.08.037","article-title":"A\u00a0randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study","volume":"48","author":"Pappone","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1125","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1126","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa050955","article-title":"Circumferential pulmonary-vein ablation for chronic atrial fibrillation","volume":"354","author":"Oral","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1127","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"Ja\u00efs","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1128","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1540-8167.2008.01275.x","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy","volume":"20","author":"Forleo","year":"2009","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/hrt.2010.207340","article-title":"Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial","volume":"97","author":"MacDonald","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1131","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1132","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation","volume":"367","author":"Cosedis Nielsen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1133","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1134","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1136","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jama.2014.467","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial","volume":"311","author":"Morillo","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1137","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1001\/jama.293.21.2634","article-title":"Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial","volume":"293","author":"Wazni","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1138","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.CIR.0000101684.88679.AB","volume":"108","author":"Wazni","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1139","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCEP.109.871665","article-title":"Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis","volume":"2","author":"P\u00e9rez","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1140","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.hrthm.2016.02.005","article-title":"Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: analysis of 89,638 procedures","volume":"13","author":"Patel","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1141","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2007.08.066","article-title":"Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications","volume":"51","author":"Waldo","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1142","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jacc.2005.06.016","article-title":"Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implication for catheter ablation","volume":"46","author":"Lee","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1143","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.109.928903","article-title":"Left atrial appendage: an underrecognized trigger site of atrial fibrillation","volume":"122","author":"Di Biase","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1144","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/europace\/eum105","article-title":"Inducible supraventricular tachycardias in patients referred for catheter ablation of atrial fibrillation","volume":"9","author":"Katritsis","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1145","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1460-9592.2001.00969.x","article-title":"Studies on the prevalence of complicated atrial arrhythmias, flutter, and fibrillation in patients with reciprocating supraventricular tachycardia before and after successful catheter ablation","volume":"24","author":"Miyamoto","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1146","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1147","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2021.11.020","article-title":"Catheter ablation for atrial fibrillation in patients\u00a0<\/=30 years of age","volume":"166","author":"Yalin","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1148","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.hrthm.2021.07.066","article-title":"Management and outcomes of atrial fibrillation in 241 healthy children and young adults: revisiting \"lone\" atrial fibrillation-a multi-institutional PACES collaborative study","volume":"18","author":"El Assaad","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1149","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1150","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCULATIONAHA.122.058575","article-title":"Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy in atrial fibrillation: the CABANA randomized clinical trial","volume":"146","author":"Chew","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1151","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/europace\/euu188","article-title":"The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy","volume":"17","author":"Aronsson","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1152","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ahj.2011.05.008","article-title":"Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial","volume":"162","author":"Disertori","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1153","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1253\/circj.CJ-13-1272","article-title":"Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation","volume":"78","author":"Senoo","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1154","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.hrthm.2017.01.038","article-title":"Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation","volume":"14","author":"Padfield","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1155","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1161\/STROKEAHA.118.021396","article-title":"Progression From paroxysmal to sustained atrial fibrillation is associated with increased adverse events","volume":"49","author":"Ogawa","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib1156","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jce.14826","article-title":"Associations of atrial fibrillation progression with clinical risk factors and clinical prognosis: a report from the Chinese Atrial Fibrillation Registry study","volume":"32","author":"Yang","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1157","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/heartjnl-2017-312569","article-title":"Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes","volume":"104","author":"R","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1158","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/jce.13115","article-title":"Left atrial size and left ventricular end-systolic dimension predict the progression of paroxysmal atrial fibrillation after catheter ablation","volume":"28","author":"Liao","year":"2017","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1159","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hrthm.2015.10.028","article-title":"Progression of atrial remodeling in patients with high-burden atrial fibrillation: implications for early ablative intervention","volume":"13","author":"Walters","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1160","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/heartjnl-2014-307043","article-title":"Heart rate is associated with progression of atrial fibrillation, independent of rhythm","volume":"101","author":"Holmqvist","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1161","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1162","first-page":"362","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"EP: Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1163","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/europace\/euac055","article-title":"Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANA","volume":"24","author":"Monahan","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1164","first-page":"Cd012088","article-title":"Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation","volume":"11","author":"Nyong","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib1165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.hroo.2020.12.017","article-title":"Catheter ablation and healthcare utilization and cost among patients with paroxysmal versus persistent atrial fibrillation","volume":"2","author":"Friedman","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2023.08.017_bib1166","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCULATIONAHA.121.055297","article-title":"Association between age and outcomes of catheter ablation versus medical therapy for atrial fibrillation: results from the CABANA trial","volume":"145","author":"Bahnson","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1167","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1168","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2020.01.011","article-title":"Treatment strategies and subsequent changes in the patient-reported quality-of-life among elderly patients with atrial fibrillation","volume":"222","author":"Miura","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1169","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0002-9149(97)00157-4","article-title":"Clinical usefulness of slow pathway ablation in patients with both paroxysmal atrioventricular nodal reentrant tachycardia and atrial fibrillation","volume":"79","author":"Delise","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1170","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0002-9149(97)00753-4","article-title":"Long-term follow-up after radiofrequency ablation of paroxysmal supraventricular tachycardia in patients with tachycardia-induced atrial fibrillation","volume":"80","author":"Weiss","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1171","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.15420\/aer.2021.37","article-title":"Prophylactic cavotricuspid isthmus ablation in atrial fibrillation without documented typical atrial flutter: a systematic review and meta-analysis","volume":"11","author":"Waranugraha","year":"2022","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib1172","first-page":"364","article-title":"Cryoballoon pulmonary vein isolation as first-line treatment for typical atrial flutter","volume":"109","author":"Gupta","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1173","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1174","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031033","article-title":"Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure","volume":"9","author":"Gao","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib1175","doi-asserted-by":"crossref","first-page":"E007094","DOI":"10.1161\/CIRCOUTCOMES.120.007094","article-title":"Economic evaluation of catheter ablation of atrial fibrillation in patients with heart failure with reduced ejection fraction","volume":"13","author":"Chew","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib1176","article-title":"Cost-utility of catheter ablation for atrial fibrillation in patients with heart failure: an economic evaluation","volume":"10","author":"Lau","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1177","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.jacc.2018.03.519","article-title":"Progression of device-detected subclinical atrial fibrillation and the risk of heart failure","volume":"71","author":"Wong","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1178","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1540-8167.2010.01845.x","article-title":"Ablation of atrial fibrillation at the time of cavotricuspid isthmus ablation in patients with atrial flutter without documented atrial fibrillation derives a better long-term benefit","volume":"22","author":"Navarrete","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1179","article-title":"Clinical outcomes of rhythm control strategies for asymptomatic atrial fibrillation according to the quality-of-life score: the CODE-AF (Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation) registry","volume":"11","author":"Kim","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1180","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1181","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1182","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.15420\/ecr.2021.38","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"17","author":"Andrade","year":"2022","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1183","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1184","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1185","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1186","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/europace\/eux013","article-title":"Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis","volume":"20","author":"Njoku","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1187","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCEP.114.001479","article-title":"Diffuse ventricular fibrosis measured by T(1) mapping on cardiac MRI predicts success of catheter ablation for atrial fibrillation","volume":"7","author":"McLellan","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1188","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jama.2014.3","article-title":"Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study","volume":"311","author":"Marrouche","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1189","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hroo.2021.11.012","article-title":"Diagnosis-to-ablation time predicts recurrent atrial fibrillation and rehospitalization following catheter ablation","volume":"3","author":"Chew","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2023.08.017_bib1190","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.008128","article-title":"Diagnosis-to-ablation time and recurrence of atrial fibrillation following catheter ablation: a systematic review and meta-analysis of observational studies","volume":"13","author":"Chew","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1191","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/pace.13805","article-title":"Predicting atrial fibrillation recurrence after ablation in patients with heart failure: validity of the APPLE and CAAP-AF risk scoring systems","volume":"42","author":"Black-Maier","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1192","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1193","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1194","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/M18-0992","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials","volume":"170","author":"Turagam","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1195","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.jacc.2014.09.053","article-title":"Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: a noninferiority randomized multicenter RADAR-AF trial","volume":"64","author":"Atienza","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1196","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1540-8167.2011.02051.x","article-title":"Randomized comparison between pulmonary vein antral isolation versus complex fractionated electrogram ablation for paroxysmal atrial fibrillation","volume":"22","author":"Chen","year":"2011","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1197","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/CIRCEP.108.798447","article-title":"Atrial fibrillation ablation strategies for paroxysmal patients: randomized comparison between different techniques","volume":"2","author":"Di Biase","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1198","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.jacc.2013.06.053","article-title":"Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial","volume":"62","author":"Katritsis","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1199","first-page":"31","article-title":"Electrical exclusion' of a critical myocardial mass by extended pulmonary vein antrum isolation for persistent atrial fibrillation treatment","volume":"6","author":"Mamchur","year":"2014","journal-title":"Interv Med Appl Sci"},{"key":"10.1016\/j.jacc.2023.08.017_bib1200","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/eurheartj\/ehq041","article-title":"Substrate\u00a0and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial","volume":"31","author":"Verma","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1201","first-page":"968","article-title":"Meta-analysis of randomized controlled trials of atrial fibrillation ablation with pulmonary vein isolation versus without","volume":"5","author":"Sau","year":"2019","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1202","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1001\/jama.2022.8831","article-title":"Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial","volume":"327","author":"Marrouche","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1203","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.hrthm.2015.12.028","article-title":"Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation","volume":"13","author":"Gianni","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1204","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jacc.2014.02.543","volume":"63","author":"Narayan","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1205","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/europace\/euaa378","article-title":"Focal impulse and rotor modulation ablation vs. pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: results from the FIRMAP AF study","volume":"23","author":"Tilz","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1206","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/jce.14870","article-title":"Targeting the ectopy-triggering ganglionated plexuses without pulmonary vein isolation prevents atrial fibrillation","volume":"32","author":"Sandler","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1207","first-page":"1766","article-title":"Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study","volume":"20","author":"Kircher","year":"2018","journal-title":"EP: Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1208","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005019","article-title":"Long-term clinical comparison of procedural end points after pulmonary vein isolation in paroxysmal atrial fibrillation: elimination of nonpulmonary vein triggers versus noninducibility","volume":"11","author":"Lee","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1209","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.109.928903","article-title":"Left atrial appendage: an underrecognized trigger site of atrial fibrillation","volume":"122","author":"Di Biase","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1210","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1211","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008993","article-title":"PRECAF randomized controlled trial","volume":"14","author":"Kuo","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1212","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/europace\/eun077","article-title":"Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study","volume":"10","author":"Wang","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1213","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/jce.14355","article-title":"Role of inducibility and its dynamic change in the outcome of catheter ablation of atrial fibrillation: a single center prospective study","volume":"31","author":"Darma","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1214","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.hrthm.2015.01.004","article-title":"Sinus rhythm restoration and arrhythmia noninducibility are major predictors of arrhythmia-free outcome after ablation for long-standing persistent atrial fibrillation: a prospective study","volume":"12","author":"Fiala","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1215","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.hrthm.2017.10.023","article-title":"Lack of prognostic value of atrial arrhythmia inducibility and change in inducibility status after catheter ablation of atrial fibrillation","volume":"15","author":"Santangeli","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1216","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/eurheartj\/ehl307","article-title":"Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor?","volume":"27","author":"Richter","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1217","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/jce.14830","article-title":"Clinical impact of eliminating nonpulmonary vein triggers of atrial fibrillation and nonpulmonary vein premature atrial contractions at initial ablation for persistent atrial fibrillation","volume":"32","author":"Tohoku","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1218","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/pace.14578","article-title":"Efficacy of ablation index-guided pulmonary vein isolation in patients with paroxysmal atrial fibrillation","volume":"45","author":"Jiang","year":"2022","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1219","first-page":"223","article-title":"Predictive value of the induction test with atrial burst pacing with regard to long-term recurrence after ablation in persistent atrial fibrillation","volume":"35","author":"Kawai","year":"2019","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1220","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/jce.13901","article-title":"Pace capture and adenosine triphosphate provocation are complementary rather than mutually exclusive methods to ensure durable pulmonary vein isolation","volume":"30","author":"Zeng","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1221","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10840-018-0436-x","article-title":"Utility of acute arrhythmia termination as an ablation endpoint for induced atrial tachyarrhythmia after complete pulmonary vein isolation during catheter ablation for persistent atrial fibrillation","volume":"54","author":"Choi","year":"2019","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1222","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/europace\/euw231","article-title":"Isolation of the posterior left atrium for patients with persistent atrial fibrillation: routine adenosine challenge for dormant posterior left atrial conduction improves long-term outcome","volume":"19","author":"McLellan","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1223","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Page","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1224","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jacc.2019.06.045","article-title":"Stroke risk in patients with atrial fibrillation undergoing electrical isolation of the left atrial appendage","volume":"74","author":"Di Biase","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1225","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007073","article-title":"Atrial fibrillation catheter ablation increases the left atrial pressure","volume":"12","author":"Park","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1226","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.hrthm.2011.02.026","article-title":"Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors","volume":"8","author":"Gibson","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1227","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/jce.13671","article-title":"Characteristics of atrial fibrillation patients suffering atrioesophageal fistula after radiofrequency catheter ablation","volume":"29","author":"Kim","year":"2018","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1228","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.hrthm.2015.04.005","article-title":"Higher incidence of esophageal lesions after ablation of atrial fibrillation related to the use of esophageal temperature probes","volume":"12","author":"Muller","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1229","first-page":"308","article-title":"Thromboembolic risk in atrial fibrillation patients with left atrial scar post-extensive ablation: a single-center experience","volume":"7","author":"Mohanty","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1230","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1231","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehw285","article-title":"Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial","volume":"37","author":"Kuck","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1232","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.112.109330","article-title":"Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation","volume":"126","author":"Piccini","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1233","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.jacc.2010.01.040","article-title":"Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect","volume":"55","author":"Wokhlu","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1234","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1161\/CIRCEP.108.824789","article-title":"Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses","volume":"2","author":"Calkins","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1235","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"2","author":"Ganesan","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1236","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.hrthm.2009.06.014","article-title":"Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study","volume":"6","author":"Bhargava","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1237","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.hrthm.2018.01.029","article-title":"Evaluation of shortness of breath after atrial fibrillation ablation-is there a stiff left atrium?","volume":"15","author":"Reddy","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1238","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/europace\/euy326","article-title":"Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation","volume":"21","author":"Szegedi","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1239","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.2019.0335","article-title":"Effect of Catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial","volume":"321","author":"Blomstr\u00f6m-Lundqvist","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1240","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2012.11.064","article-title":"Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial","volume":"61","author":"Packer","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1241","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/jce.12038","article-title":"Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation","volume":"24","author":"Pokushalov","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1242","first-page":"582","article-title":"Electrical posterior box isolation in repeat ablation for atrial fibrillation: a prospective randomized clinical study","volume":"8","author":"Kim","year":"2022","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1243","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/clc.23309","article-title":"Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation\/flutter: insights from the ATHENA study","volume":"43","author":"Vamos","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1244","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/eurheartj\/ehx666","article-title":"PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial","volume":"39","author":"Duytschaever","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCEP.110.955393","article-title":"Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study","volume":"4","author":"Leong-Sit","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1246","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/jce.14042","article-title":"Natural course of acquired pulmonary vein stenosis after radiofrequency ablation for atrial fibrillation-is routine follow-up imaging indicated or not?","volume":"30","author":"Schoene","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1247","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"Jais","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1248","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCEP.113.000495","article-title":"Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation","volume":"6","author":"Pokushalov","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1249","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/CIRCULATIONAHA.108.839639","article-title":"Antiarrhythmics after ablation of atrial fibrillation (5A study)","volume":"120","author":"Roux","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1250","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/eurheartj\/ehv501","article-title":"Efficacy of antiarrhythmic drugs short-term use after catheter ablation for atrial fibrillation (EAST-AF) trial","volume":"37","author":"Kaitani","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1251","article-title":"Efficacy of short-term antiarrhythmic drugs use after catheter ablation of atrial fibrillation-a systematic review with meta-analyses and trial sequential analyses of randomized controlled trials","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib1252","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/1060028016653140","article-title":"Short-term antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"50","author":"Xu","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacc.2023.08.017_bib1253","first-page":"238","article-title":"Effect of antiarrhythmic drug initiation on readmission after catheter ablation for atrial fibrillation","volume":"1","author":"Noseworthy","year":"2015","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1254","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.hrthm.2014.03.003","volume":"11","author":"Di Biase","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hrthm.2017.09.011","article-title":"An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation","volume":"15","author":"Cardoso","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1256","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1093\/eurheartj\/ehy176","article-title":"Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation","volume":"39","author":"Kirchhof","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1257","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/jce.12928","article-title":"Apixaban versus warfarin for the prevention of periprocedural cerebral thromboembolism in atrial fibrillation ablation: multicenter prospective randomized study","volume":"27","author":"Kuwahara","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1258","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1701005","article-title":"Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation","volume":"376","author":"Calkins","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1259","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1093\/eurheartj\/ehz190","article-title":"Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial","volume":"40","author":"Hohnloser","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1260","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/eurheartj\/ehv177","article-title":"Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation","volume":"36","author":"Cappato","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1261","first-page":"580","article-title":"A\u00a0prospective randomized trial of apixaban dosing during atrial fibrillation ablation: the AEIOU trial","volume":"4","author":"Reynolds","year":"2018","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1262","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.1994","article-title":"Safety and efficacy of minimally interrupted dabigatran vs uninterrupted warfarin therapy in adults undergoing atrial fibrillation catheter ablation: a randomized clinical trial","volume":"2","author":"Nogami","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib1263","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/europace\/euab175","article-title":"Meta-analysis of controlled studies on minimally interrupted vs. continuous use of non-vitamin K antagonist oral anticoagulants in catheter ablation for atrial fibrillation","volume":"23","author":"van Vugt","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1264","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1265","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1266","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","article-title":"Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial","volume":"34","author":"Al-Khatib","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1267","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/europace\/eux356","article-title":"Burden of atrial high-rate episodes and risk of stroke: a systematic review","volume":"20","author":"Uittenbogaart","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1268","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCOUTCOMES.111.963108","article-title":"Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis","volume":"5","author":"Reynolds","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib1269","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1270","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1271","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.112.109330","article-title":"Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation","volume":"126","author":"Piccini","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1272","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1273","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark","volume":"36","author":"Karasoy","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1274","article-title":"Patterns of anticoagulation use and cardioembolic risk after catheter ablation for atrial fibrillation","volume":"4","author":"Noseworthy","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2022.05.003","article-title":"Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: rationale and design of the OPTION randomized trial","volume":"251","author":"Wazni","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1276","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.113.003862","article-title":"In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures","volume":"128","author":"Deshmukh","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1277","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1093\/eurheartj\/ehy452","article-title":"Incidence of complications related to catheter ablation of atrial fibrillation and atrial flutter: a nationwide in-hospital analysis of administrative data for Germany in 2014","volume":"39","author":"Steinbeck","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1278","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007944","article-title":"Procedural patterns and safety of atrial fibrillation ablation: findings from Get With The Guidelines-Atrial Fibrillation","volume":"13","author":"Loring","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1279","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1111\/jce.14758","article-title":"Sex-based differences in procedural complications associated with atrial fibrillation catheter ablation: a systematic review and meta-analysis","volume":"31","author":"Campbell","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1280","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.120.051558","article-title":"Association between sex and treatment outcomes of atrial fibrillation ablation versus drug therapy: results from the CABANA trial","volume":"143","author":"Russo","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1281","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1046\/j.1460-9592.2003.00309.x","article-title":"Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing","volume":"26","author":"Stambler","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1282","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0735-1097(01)01326-2","article-title":"Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators","volume":"38","author":"Skanes","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1283","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/0735-1097(92)90616-U","article-title":"Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing","volume":"19","author":"Hesselson","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1284","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(97)03425-9","article-title":"Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome","volume":"350","author":"Andersen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib1285","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1056\/NEJMoa013040","article-title":"Ventricular pacing or dual-chamber pacing for sinus node dysfunction","volume":"346","author":"Lamas","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1286","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1540-8159.2011.03192.x","article-title":"The influence of atrial and ventricular pacing on the incidence of atrial fibrillation: a meta-analysis","volume":"34","author":"Elkayam","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1287","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0735-1097(02)02345-8","article-title":"Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator","volume":"40","author":"Gillis","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1288","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0735-1097(03)00426-1","article-title":"The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias","volume":"41","author":"Lee","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1289","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1046\/j.1540-8167.2001.01121.x","article-title":"Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy","volume":"12","author":"Israel","year":"2001","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1290","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.hrthm.2005.04.027","article-title":"High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation","volume":"2","author":"Gillis","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1291","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.hrthm.2015.04.015","article-title":"New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: results from the MINERVA randomized multicenter international trial","volume":"12","author":"Padeletti","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1292","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/eurheartj\/ehu165","article-title":"Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1293","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jce.15551","article-title":"Characteristics of successful reactive atrial-based antitachycardia pacing in patients with cardiac implantable electronic devices: history of catheter ablation of atrial fibrillation as a predictor of high treatment efficacy","volume":"33","author":"Nakagomi","year":"2022","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1294","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/europace\/euac132","article-title":"New-onset atrial fibrillation following left bundle branch area pacing vs. right ventricular pacing: a two-centre prospective cohort study","volume":"25","author":"Zhu","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1295","article-title":"Development of new-onset or progressive atrial fibrillation in patients with permanent His bundle pacing versus right ventricular pacing: results from the RUSH HBP registry","volume":"9","author":"Ravi","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1296","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0735-1097(03)00780-0","article-title":"A\u00a0new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT)","volume":"42","author":"Carlson","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1297","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.hrthm.2012.06.012","article-title":"Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT","volume":"9","author":"Hohnloser","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1298","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/europace\/eum253","article-title":"Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study","volume":"9","author":"Camm","year":"2007","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1299","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.hrthm.2019.02.020","article-title":"Implication of ventricular pacing burden and atrial pacing therapies on the progression of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Munawar","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1300","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"Sweeney","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1301","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa071880","article-title":"Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease","volume":"357","author":"Sweeney","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1302","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.hrthm.2015.06.041","article-title":"Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study","volume":"12","author":"Ricci","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1303","first-page":"282","article-title":"Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis","volume":"19","author":"Shurrab","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1304","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa042283","article-title":"Single-chamber versus dual-chamber pacing for high-grade atrioventricular block","volume":"353","author":"Toff","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1305","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/jce.14810","article-title":"Occurrence of persistent atrial fibrillation during pacing for sinus node disease: the influence of His bundle pacing versus managed ventricular pacing","volume":"32","author":"Pastore","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1306","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/jce.14376","article-title":"Real-world behavior of CRT pacing using the AdaptivCRT algorithm on patient outcomes: effect on mortality and atrial fibrillation incidence","volume":"31","author":"Singh","year":"2020","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1307","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.hrthm.2019.05.012","article-title":"Adaptive cardiac resynchronization therapy is associated with decreased risk of incident atrial fibrillation compared to standard biventricular pacing: a real-world analysis of 37,450 patients followed by remote monitoring","volume":"16","author":"Hsu","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1308","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007260","article-title":"Adaptive cardiac resynchronization therapy reduces atrial fibrillation incidence in heart failure patients with prolonged AV conduction: the adaptive CRT randomized trial","volume":"12","author":"Gasparini","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1309","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jamacardio.2016.5404","article-title":"Concomitant atrial fibrillation surgery for people undergoing cardiac surgery","volume":"2","author":"Huffman","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1310","first-page":"CD011814","article-title":"Concomitant atrial fibrillation surgery for people undergoing cardiac surgery","volume":"8","author":"Huffman","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib1311","first-page":"484","article-title":"Surgical ablation for atrial fibrillation","volume":"373","author":"Gillinov","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1312","article-title":"Patterns of anticoagulation use and cardioembolic risk after catheter ablation for atrial fibrillation","volume":"4","author":"Noseworthy","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1313","first-page":"341","article-title":"Comparative effectiveness of hybrid ablation versus endocardial catheter ablation alone in patients with persistent atrial fibrillation","volume":"3","author":"Kress","year":"2017","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1314","doi-asserted-by":"crossref","first-page":"ezac515","DOI":"10.1093\/ejcts\/ezac515","article-title":"Convergent ablation for persistent atrial fibrillation: outcomes from a single-centre real-world experience","volume":"63","author":"Mannakkara","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1315","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jtcvs.2013.06.057","article-title":"European experience of the convergent atrial fibrillation procedure: multicenter outcomes in consecutive patients","volume":"147","author":"Gersak","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1316","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-5223(19)36684-X","article-title":"The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure","volume":"101","author":"Cox","year":"1991","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1317","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.jtcvs.2019.06.062","article-title":"Prevalence of atrial fibrillation before cardiac surgery and factors associated with concomitant ablation","volume":"159","author":"McCarthy","year":"2020","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1318","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jtcvs.2017.09.095","article-title":"Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery","volume":"155","author":"Musharbash","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1319","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.athoracsur.2018.08.022","article-title":"Surgical atrial fibrillation ablation improves long-term survival: a multicenter analysis","volume":"107","author":"Iribarne","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1320","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jtcvs.2018.07.099","article-title":"Survival after surgical ablation for atrial fibrillation in mitral valve surgery: analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK)","volume":"157","author":"Suwalski","year":"2019","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1321","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jtcvs.2019.10.159","article-title":"Ablation of atrial fibrillation during coronary artery bypass grafting: late outcomes in a Medicare population","volume":"161","author":"Malaisrie","year":"2021","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1322","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.athoracsur.2017.05.016","article-title":"Surgical ablation of atrial fibrillation in the United States: trends and propensity matched outcomes","volume":"104","author":"Badhwar","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1323","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/europace\/eut128","article-title":"Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation","volume":"15","author":"Eitel","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1324","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.009288","article-title":"Hybrid convergent procedure for the treatment of persistent and long-standing persistent atrial fibrillation: results of CONVERGE clinical trial","volume":"13","author":"DeLurgio","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1325","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","volume":"8","author":"Melenovsky","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib1326","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0735-1097(02)02373-2","article-title":"Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women","volume":"40","author":"Tsang","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1327","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehr378","article-title":"Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study","volume":"33","author":"Rosenberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1328","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ccep.2020.11.004","article-title":"Atrial fibrillation and heart failure: epidemiology, pathophysiology, prognosis, and management","volume":"13","author":"Ariyaratnam","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.jacc.2023.08.017_bib1329","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1330","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A\u00a0meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib1331","first-page":"565","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.jacc.2023.08.017_bib1332","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: a systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1333","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1093\/eurheartj\/ehy626","article-title":"Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry","volume":"39","author":"Zafrir","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1334","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1335","first-page":"594","article-title":"Atrial fibrillation burden and clinical outcomes in heart failure: the CASTLE-AF trial","volume":"7","author":"Brachmann","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1336","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1093\/eurheartj\/ehz443","article-title":"Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1337","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1338","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A\u00a0randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1339","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A\u00a0randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1340","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007731","article-title":"Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial","volume":"12","author":"Kuck","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1341","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/hrt.2010.207340","article-title":"Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial","volume":"97","author":"MacDonald","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1342","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1343","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.7150\/ijms.52257","article-title":"Catheter ablation compared with medical therapy for atrial fibrillation with heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Pan","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jacc.2023.08.017_bib1344","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","article-title":"Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: results from the RAFT-AF trial","volume":"145","author":"Parkash","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1345","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1346","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/M18-0992","article-title":"Catheter ablation of atrial fibrillation in patients with heart failure: a meta-analysis of randomized controlled trials","volume":"170","author":"Turagam","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1347","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1348","first-page":"981","article-title":"Catheter ablation in patients with atrial fibrillation and heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"38","author":"Siddiqui","year":"2022","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1349","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.jacc.2003.07.020","article-title":"Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?","volume":"42","author":"Khand","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1350","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.2020.23138","article-title":"Effect of digoxin vs bisoprolol for heart rate control in atrial fibrillation on patient-reported quality of life: the RATE-AF randomized clinical trial","volume":"324","author":"Kotecha","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1351","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0002-9149(97)00962-4","article-title":"Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias","volume":"81","author":"Clemo","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1352","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00003246-200106000-00011","article-title":"Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias","volume":"29","author":"Delle Karth","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1353","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/01.CIR.98.10.953","article-title":"Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study","volume":"98","author":"Brignole","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1354","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1009795330454","article-title":"The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators","volume":"2","author":"Kay","year":"1998","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1355","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0735-1097(03)00338-3","article-title":"The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT)","volume":"41","author":"Weerasooriya","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1356","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1093\/eurheartj\/ehab569","article-title":"AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial","volume":"42","author":"Brignole","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1357","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jacc.2011.10.891","article-title":"Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure: a systematic review","volume":"59","author":"Ganesan","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1358","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000937","article-title":"Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies","volume":"6","author":"Mustafa","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1359","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/ejhf.1117","article-title":"Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations","volume":"20","author":"Gasparini","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib1360","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.CIR.0000135472.28234.CC","article-title":"Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia","volume":"110","author":"Nerheim","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1361","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.hrthm.2013.12.031","article-title":"Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control","volume":"11","author":"Nedios","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1362","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1363","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1364","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1751-7133.2012.00309.x","article-title":"Heart rate control in patients with chronic atrial fibrillation and heart failure","volume":"19","author":"Silvet","year":"2013","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib1365","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/pace.14252","article-title":"Effectiveness and safety of AV node ablation after His bundle pacing in patients with uncontrolled atrial arrhythmias","volume":"44","author":"Mori\u00f1a-V\u00e1zquez","year":"2021","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1366","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.hrthm.2022.03.1222","article-title":"Atrioventricular junction ablation in patients with conduction system pacing leads: a comparison of His-bundle vs left bundle branch area pacing leads","volume":"19","author":"Pillai","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1367","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.hroo.2022.04.005","article-title":"Conduction system pacing versus conventional pacing in patients undergoing atrioventricular node ablation: nonrandomized, on-treatment comparison","volume":"3","author":"Vijayaraman","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2023.08.017_bib1368","doi-asserted-by":"crossref","first-page":"iv10","DOI":"10.1093\/europace\/eux263","article-title":"Atrioventricular node ablation and His bundle pacing","volume":"19","author":"Vijayaraman","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1369","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1370","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1371","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2459\/01.JCM.0000260841.30415.62","article-title":"Tachycardia-induced cardiomyopathy: mechanisms of heart failure and clinical implications","volume":"8","author":"Calo","year":"2007","journal-title":"J\u00a0Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.jacc.2023.08.017_bib1372","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jacc.2015.08.038","article-title":"Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management","volume":"66","author":"Gopinathannair","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1373","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/hrt.2008.158931","article-title":"A\u00a0randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study)","volume":"95","author":"Shelton","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1374","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.amjcard.2005.11.044","article-title":"Ventricular remodeling during long-term right ventricular pacing following His bundle ablation","volume":"97","author":"Vernooy","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1375","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jacc.2006.05.072","article-title":"Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation","volume":"48","author":"Tops","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1376","doi-asserted-by":"crossref","DOI":"10.1161\/HAE.0000000000000078","article-title":"Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association","volume":"14","author":"Gopinathannair","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1377","doi-asserted-by":"crossref","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2023.08.017_bib1378","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.289.7.871","article-title":"Association of serum digoxin concentration and outcomes in patients with heart failure","volume":"289","author":"Rathore","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1379","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/oxfordjournals.eurheartj.a060945","article-title":"Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study","volume":"16","author":"Hou","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1380","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1540-8167.2003.03002.x","article-title":"Pulmonary vein isolation during atrial fibrillation: insight into the mechanism of pulmonary vein firing","volume":"14","author":"Nakagawa","year":"2003","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1381","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/eurjhf\/hfs036","article-title":"Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode","volume":"14","author":"Chatterjee","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib1382","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2022.06.058","article-title":"Atrioventricular node ablation and pacing for atrial tachyarrhythmias: a meta-analysis of postoperative outcomes","volume":"363","author":"Baudo","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1383","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0735-1097(02)01932-0","article-title":"Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study","volume":"40","author":"Linde","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1384","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2008.06.043","article-title":"Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"52","author":"Upadhyay","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1385","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.hrthm.2011.02.014","article-title":"Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis","volume":"8","author":"Wilton","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1386","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.hrthm.2011.04.015","article-title":"Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival","volume":"8","author":"Hayes","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1387","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa1001337","article-title":"Lenient versus strict rate control in patients with atrial fibrillation","volume":"362","author":"Van Gelder","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1388","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1540-8159.2011.03124.x","article-title":"Prognostic significance of atrial arrhythmias in a primary prevention ICD population","volume":"34","author":"van Gelder","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1389","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/eurjhf\/hfr046","article-title":"Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy","volume":"13","author":"Boriani","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib1390","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40261-018-0631-7","article-title":"Safety of intravenous diltiazem in reduced ejection fraction heart failure with rapid atrial fibrillation","volume":"38","author":"Jandali","year":"2018","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jacc.2023.08.017_bib1391","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajem.2022.03.058","article-title":"Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department","volume":"58","author":"Hasbrouck","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1392","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.94.3.346","article-title":"Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial","volume":"94","author":"Figulla","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1393","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1394","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.amjcard.2021.11.020","article-title":"Catheter ablation for atrial fibrillation in patients\u00a0<\/=30 years of age","volume":"166","author":"Yalin","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1395","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jpeds.2012.09.016","article-title":"Lone atrial fibrillation in the young - perhaps not so \"lone\u201d?","volume":"162","author":"Ceresnak","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jacc.2023.08.017_bib1396","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCULATIONAHA.106.621896","article-title":"Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification","volume":"114","author":"Sauer","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1397","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jamacardio.2021.3370","article-title":"Early-onset atrial fibrillation and the prevalence of rare variants in cardiomyopathy and arrhythmia genes","volume":"6","author":"Yoneda","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1398","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002713","article-title":"Broad genetic testing in a clinical setting uncovers a high prevalence of titin loss-of-function variants in very early onset atrial fibrillation","volume":"12","author":"Goodyer","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1399","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1400","first-page":"1265","article-title":"Outcomes of pulmonary vein isolation in athletes","volume":"6","author":"Mandsager","year":"2020","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1401","first-page":"1266","article-title":"Long-term efficacy and impact on quality of life of atrial fibrillation catheter ablation in competitive athletes","volume":"62","author":"Toso","year":"2022","journal-title":"J\u00a0Sports Med Phys Fitness"},{"key":"10.1016\/j.jacc.2023.08.017_bib1402","article-title":"Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women","volume":"3","author":"Azarbal","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1403","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCULATIONAHA.108.785626","article-title":"Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study","volume":"118","author":"Mozaffarian","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1404","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bjsports-2021-103994","article-title":"Risk of atrial fibrillation in athletes: a systematic review and meta-analysis","volume":"55","author":"Newman","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1405","first-page":"25","article-title":"Age modifies the risk of atrial fibrillation among athletes: a systematic literature review and meta-analysis","volume":"18","author":"Ayinde","year":"2018","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1406","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ehjci\/jeaa183","article-title":"Differing mechanisms of atrial fibrillation in athletes and non-athletes: alterations in atrial structure and function","volume":"21","author":"Trivedi","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2023.08.017_bib1407","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130031","article-title":"Relationship between inflammatory cytokines and indices of cardiac dysfunction following intense endurance exercise","volume":"10","author":"La Gerche","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib1408","first-page":"921","article-title":"Atrial fibrillation in athletes: a lesson in the virtue of moderation","volume":"3","author":"Estes","year":"2017","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1409","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1410","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1411","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004378","article-title":"Associations of Epicardial, abdominal, and overall adiposity with atrial fibrillation","volume":"9","author":"Wong","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1412","first-page":"139","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1413","first-page":"649","article-title":"Outcomes of direct oral anticoagulants in atrial fibrillation patients across different body mass index categories","volume":"7","author":"Barakat","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1414","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/europace\/euz361","article-title":"Impact of weight on the efficacy and safety of direct-acting oral anticoagulants in patients with non-valvular atrial fibrillation: a meta-analysis","volume":"22","author":"Malik","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1415","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIRCULATIONAHA.118.037955","article-title":"Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and extremes in body weight","volume":"139","author":"Hohnloser","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1416","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/eurheartj\/ehy861","article-title":"Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial","volume":"40","author":"Boriani","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1417","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.amjcard.2017.03.028","volume":"119","author":"Balla","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1418","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11239-013-0891-2","article-title":"Pharmacokinetics of rivaroxaban after bariatric surgery: a case report","volume":"36","author":"Mahlmann","year":"2013","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2023.08.017_bib1419","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/jth.15823","article-title":"Direct oral anticoagulants after bariatric surgery-what is the evidence?","volume":"20","author":"Leong","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib1420","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.STR.31.11.2628","article-title":"Predictors of cerebrovascular events and death among patients with valvular heart disease: a population-based study","volume":"31","author":"Petty","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib1421","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Page","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1422","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0002-9149(02)03257-5","article-title":"Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states","volume":"91","author":"Roth","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1423","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/CIRCULATIONAHA.114.011154","article-title":"Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients","volume":"130","author":"Pappone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1424","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0002-9149(97)00736-4","article-title":"Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia in children and adolescents without structural heart disease. Pediatric EP Society, Radiofrequency Catheter Ablation Registry","volume":"80","author":"Kugler","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1425","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/01.CIR.85.4.1337","article-title":"Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome","volume":"85","author":"Calkins","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1426","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199106063242301","article-title":"Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current","volume":"324","author":"Jackman","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1427","first-page":"265","article-title":"Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients","volume":"9","author":"Belhassen","year":"2007","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1428","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.CIR.55.1.15","article-title":"Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome","volume":"55","author":"Sellers","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1429","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/hc4101.097538","article-title":"Electrophysiological effects of ibutilide in patients with accessory pathways","volume":"104","author":"Glatter","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1430","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0002-8703(96)90098-8","article-title":"Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation","volume":"131","author":"Boriani","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1431","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1540-8159.2008.01086.x","article-title":"Precipitation of ventricular fibrillation by intravenous diltiazem and metoprolol in a young patient with occult Wolff-Parkinson-White syndrome","volume":"31","author":"Kim","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1432","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/01.CIR.56.2.260","article-title":"Digitalis in the pre-excitation syndrome. Analysis during atrial fibrillation","volume":"56","author":"Sellers","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1433","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11739-010-0385-6","article-title":"Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation","volume":"5","author":"Simonian","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1434","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.CIR.65.2.348","article-title":"Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil","volume":"65","author":"Gulamhusein","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1435","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.CIR.87.3.866","article-title":"A\u00a0population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-1989","volume":"87","author":"Munger","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1436","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1253\/jcj.54.10_1331","article-title":"Prediction of a fatal atrial fibrillation in patients with asymptomatic Wolff-Parkinson-White pattern","volume":"54","author":"Fukatani","year":"1990","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1437","doi-asserted-by":"crossref","first-page":"38A","DOI":"10.1016\/0002-9149(92)91076-G","article-title":"Atrial fibrillation in the Wolff-Parkinson-White syndrome","volume":"70","author":"Pietersen","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1438","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM197911153012003","article-title":"Ventricular fibrillation in the Wolff-Parkinson-White syndrome","volume":"301","author":"Klein","year":"1979","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1439","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa035345","article-title":"A\u00a0randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome","volume":"349","author":"Pappone","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1440","first-page":"2550","article-title":"A\u00a0randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group","volume":"92","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1441","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/oxfordjournals.eurheartj.a060852","article-title":"Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group","volume":"16","author":"Chimienti","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1442","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1443","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2023.08.017_bib1444","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1002\/ehf2.13563","article-title":"Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"8","author":"Kubo","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacc.2023.08.017_bib1445","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/STROKEAHA.121.034213","article-title":"Ischemic stroke in patients with hypertrophic cardiomyopathy according to presence or absence of atrial fibrillation","volume":"53","author":"Fauchier","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.jacc.2023.08.017_bib1446","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00392-020-01730-w","article-title":"Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review","volume":"110","author":"Alphonse","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1447","doi-asserted-by":"crossref","first-page":"24219","DOI":"10.18632\/aging.104133","article-title":"Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study","volume":"12","author":"Hsu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jacc.2023.08.017_bib1448","article-title":"Utilization and complications of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"9","author":"Rozen","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1449","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cjca.2013.02.016","article-title":"Electrophysiologic considerations in congenital heart disease and their relationship to heart failure","volume":"29","author":"Escudero","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1450","first-page":"438","article-title":"Etiology of atrial fibrillation in patients with complex congenital heart disease - for a better treatment strategy","volume":"76","author":"Miyazaki","year":"2020","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1451","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1161\/CIRCULATIONAHA.113.005817","article-title":"Specialized adult congenital heart disease care: the impact of policy on mortality","volume":"129","author":"Mylotte","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1452","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.hrthm.2018.12.024","article-title":"Safety and outcomes of catheter ablation for atrial fibrillation in adults with congenital heart disease: a multicenter registry study","volume":"16","author":"Liang","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1453","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.hrthm.2021.07.009","article-title":"Impact of specialized electrophysiological care on the outcome of catheter ablation for supraventricular tachycardias in adults with congenital heart disease: independent risk factors and gender aspects","volume":"18","author":"Fischer","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1454","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.amjcard.2013.07.029","article-title":"Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias","volume":"112","author":"Koyak","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1455","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/europace\/euz157","article-title":"Efficacy of catheter ablation for atrial fibrillation in patients with congenital heart disease","volume":"21","author":"Guarguagli","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1456","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1747-0803.2012.00649.x","article-title":"Pulmonary vein isolation for the treatment of drug-refractory atrial fibrillation in adults with congenital heart disease","volume":"7","author":"Philip","year":"2012","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib1457","doi-asserted-by":"crossref","first-page":"191","DOI":"10.15420\/2017.2017.15.1","article-title":"Ablation of atrial fibrillation in patients with congenital heart disease","volume":"6","author":"Refaat","year":"2017","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib1458","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijcard.2016.08.223","article-title":"Thromboprophylaxis for atrial arrhythmias in congenital heart disease: a multicenter study","volume":"223","author":"Khairy","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1459","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2017.06.034","article-title":"Increasing prevalence of atrial fibrillation and permanent atrial arrhythmias in congenital heart disease","volume":"70","author":"Labombarda","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1460","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jacc.2018.08.1029","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1461","first-page":"733","article-title":"Catheter ablation for atrial fibrillation in adults with congenital heart disease: lessons learned from more than 10 years following a sequential ablation approach","volume":"4","author":"Sohns","year":"2018","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1462","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.hrthm.2014.05.009","article-title":"PACES\/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease. Developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS)","volume":"11","author":"Khairy","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1463","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0735-1097(91)90586-X","article-title":"Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group","volume":"18","author":"Fish","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1464","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1001\/jama.1993.03510200057032","article-title":"Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST)","volume":"270","author":"Epstein","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1465","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.100.2.149","article-title":"Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease","volume":"100","author":"Thorne","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1466","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ijcard.2012.02.015","article-title":"Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study","volume":"167","author":"Stan","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1467","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.hrthm.2016.07.016","article-title":"Use of dofetilide in adult patients with atrial arrhythmias and congenital heart disease: a PACES collaborative study","volume":"13","author":"El-Assaad","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2023.08.017_bib1468","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1469","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1056\/NEJMoa0800456","article-title":"Increased mortality after dronedarone therapy for severe heart failure","volume":"358","author":"Kober","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1470","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00392-019-01580-1","article-title":"Atrial fibrillation ablation in adults with congenital heart disease on uninterrupted oral anticoagulation is safe and efficient","volume":"109","author":"Kottmaier","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1471","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4330\/wjc.v11.i5.149","article-title":"Feasibility and safety of cryoballoon ablation for atrial fibrillation in patients with congenital heart disease","volume":"11","author":"Abadir","year":"2019","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1472","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.hroo.2021.10.005","article-title":"Arrhythmias in adults with congenital heart disease and heart failure","volume":"2","author":"Bessiere","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2023.08.017_bib1473","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.acvd.2018.04.003","article-title":"Risk of thromboembolic complications in adult congenital heart disease: a literature review","volume":"111","author":"Karsenty","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib1474","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2019.06.014","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study","volume":"299","author":"Yang","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1475","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.athoracsur.2019.07.056","article-title":"Preoperative \u03b2-blockers as a coronary surgery quality metric: the lack of evidence of efficacy","volume":"109","author":"Filardo","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1476","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1477","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2017.12.029","article-title":"Amiodarone protocol provides cost-effective reduction in postoperative atrial fibrillation","volume":"105","author":"Mehaffey","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1478","doi-asserted-by":"crossref","first-page":"152r","DOI":"10.1016\/S0002-9149(99)00716-X","article-title":"Intravenous antiarrhythmic regimens with focus on amiodarone for prophylaxis of atrial fibrillation after open heart surgery","volume":"84","author":"Guarnieri","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1479","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.294.24.3093","article-title":"Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial","volume":"294","author":"Mitchell","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1480","article-title":"Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery","volume":"2013","author":"Arsenault","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib1481","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/S0140-6736(21)02490-9","article-title":"Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial","volume":"398","author":"Gaudino","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib1482","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.athoracsur.2020.05.104","article-title":"Postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis","volume":"111","author":"Eikelboom","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1483","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/CIRCULATIONAHA.111.026153","article-title":"Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1484","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1485","first-page":"1387","article-title":"Colchicine for prevention of atrial fibrillation after cardiac surgery in the early postoperative period","volume":"11","author":"Shvartz","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1486","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.athoracsur.2019.07.056","article-title":"Preoperative \u03b2-blockers as a coronary surgery quality metric: the lack of evidence of efficacy","volume":"109","author":"Filardo","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1487","article-title":"Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery","volume":"2013","author":"Arsenault","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib1488","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/jamainternmed.2014.2356","article-title":"Preoperative beta-blocker use in coronary artery bypass grafting surgery: national database analysis","volume":"174","author":"Brinkman","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1489","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/ALN.0000000000000901","article-title":"Effects of preoperative beta-blocker use on clinical outcomes after coronary artery bypass grafting: a report from the Japanese Cardiovascular Surgery Database","volume":"124","author":"Kohsaka","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2023.08.017_bib1490","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1491","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.athoracsur.2022.03.062","article-title":"Clinical course of postoperative atrial fibrillation after cardiac surgery and long-term outcome","volume":"114","author":"Rezk","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1492","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12959-021-00342-2","article-title":"Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis","volume":"19","author":"Frag\u00e3o-Marques","year":"2021","journal-title":"Thromb J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1493","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/CIRCULATIONAHA.111.026153","article-title":"Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1494","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1495","first-page":"1387","article-title":"Colchicine for prevention of atrial fibrillation after cardiac surgery in the early postoperative period","volume":"11","author":"Shvartz","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1496","first-page":"130","article-title":"Atrial fibrillation detected initially during acute medical illness: a systematic review","volume":"8","author":"McIntyre","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1497","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.114.014058","article-title":"Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study","volume":"131","author":"Lubitz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1498","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007716","article-title":"Initial precipitants and recurrence of atrial fibrillation","volume":"13","author":"Wang","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1499","first-page":"1134","article-title":"The incidence and natural progression of new-onset postoperative atrial fibrillation","volume":"7","author":"Abdelmoneim","year":"2021","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1500","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1111\/jce.15126","article-title":"Atrial fibrillation recurrence and spontaneous conversion to sinus rhythm after cardiac surgery: insights from 426 patients with continuous rhythm monitoring","volume":"32","author":"Charitos","year":"2021","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1501","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/pace.12949","article-title":"Management of new-onset postoperative atrial fibrillation utilizing insertable cardiac monitor technology to observe recurrence of AF (MONITOR-AF)","volume":"39","author":"El-Chami","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1502","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacc.2017.04.054","article-title":"Treating specialty and outcomes in newly diagnosed atrial fibrillation: from the TREAT-AF study","volume":"70","author":"Perino","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1503","first-page":"1261","article-title":"Cryptogenic stroke and atrial fibrillation","volume":"371","author":"Sanna","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1504","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.21867","article-title":"Effect of continuous electrocardiogram monitoring on detection of undiagnosed atrial fibrillation after hospitalization for cardiac surgery: a randomized clinical trial","volume":"4","author":"Ha","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib1505","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jamacardio.2016.2181","article-title":"Practice patterns and outcomes associated with use of anticoagulation among patients with atrial fibrillation during sepsis","volume":"1","author":"Walkey","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1506","first-page":"386","article-title":"Anticoagulant use\u00a0and risk of ischemic stroke and bleeding in patients with secondary atrial fibrillation associated with acute coronary syndromes, acute pulmonary disease, or sepsis","volume":"4","author":"Quon","year":"2018","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1507","first-page":"929","article-title":"Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalization","volume":"19","author":"Massera","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1508","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1164\/rccm.201603-0618OC","article-title":"Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. a cohort study","volume":"195","author":"Klein Klouwenberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1509","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s13054-014-0688-5","article-title":"Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review","volume":"18","author":"Kuipers","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jacc.2023.08.017_bib1510","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1001\/jama.2011.1615","article-title":"Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis","volume":"306","author":"Walkey","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2023.08.017_bib1511","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12630-021-01944-0","article-title":"Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysis","volume":"68","author":"McIntyre","year":"2021","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jacc.2023.08.017_bib1512","doi-asserted-by":"crossref","first-page":"e676","DOI":"10.1161\/CIR.0000000000001133","article-title":"Atrial Fibrillation occurring during acute hospitalization: a scientific statement from the American Heart Association","volume":"147","author":"Chyou","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1513","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028468","article-title":"Comparative\u00a0thromboembolic risk in atrial fibrillation with and without a secondary precipitant-Danish nationwide cohort study","volume":"9","author":"Gundlund","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacc.2023.08.017_bib1514","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0166","article-title":"Efficacy and safety of anticoagulation in thyrotoxic atrial fibrillation: a systematic review and meta-analysis","volume":"11","author":"Tng","year":"2022","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jacc.2023.08.017_bib1515","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1516","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2023.08.017_bib1517","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/archinte.164.15.1675","article-title":"Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study","volume":"164","author":"Frost","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1518","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0002-9343(82)90850-6","article-title":"Management of atrial fibrillation in the post-thyrotoxic state","volume":"72","author":"Nakazawa","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1519","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/105072502760143863","article-title":"Hyperthyroidism and the management of atrial fibrillation","volume":"12","author":"Shimizu","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.jacc.2023.08.017_bib1520","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1521","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2169\/internalmedicine.51.7302","article-title":"Short-term\u00a0effects of beta-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease","volume":"51","author":"Tagami","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1522","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0954-6820.1979.tb13463.x","article-title":"Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism","volume":"206","author":"Nilsson","year":"1979","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jacc.2023.08.017_bib1523","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2125.1978.tb04590.x","article-title":"Comparative trial of atenolol and propranolol in hyperthyroidism","volume":"6","author":"McDevitt","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1524","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000658-200101000-00010","article-title":"Oxygen consumption in patients with hyperthyroidism before and after treatment with beta-blockade versus thyrostatic treatment: a prospective randomized study","volume":"233","author":"Jansson","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1525","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2165\/00003495-198427050-00003","article-title":"Use of beta-adrenoceptor blocking drugs in hyperthyroidism","volume":"27","author":"Feely","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2023.08.017_bib1526","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.amjcard.2019.07.046","article-title":"Characteristics and outcomes of atrial fibrillation in patients with thyroid disease (from the ARISTOTLE trial)","volume":"124","author":"Goldstein","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1527","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5603\/CJ.2011.0022","article-title":"Short-term outcome of early electrical cardioversion for atrial fibrillation in hyperthyroid versus euthyroid patients","volume":"19","author":"Ari","year":"2012","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1528","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","article-title":"Thyroid hormones and cardiovascular function and diseases","volume":"71","author":"Razvi","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1529","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjmed.2014.07.014","article-title":"History of thyroid disorders in relation to clinical outcomes in atrial fibrillation","volume":"128","author":"Bruere","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113048","article-title":"Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib1531","first-page":"CD003566","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease","volume":"4","author":"Salpeter","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2023.08.017_bib1532","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa1908142","article-title":"Metoprolol for the prevention of acute exacerbations of COPD","volume":"381","author":"Dransfield","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1533","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","article-title":"Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension","volume":"153","author":"Tongers","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1534","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2011.02.059","article-title":"Right atrial flutter isthmus ablation is feasible and results in acute clinical improvement in patients with persistent atrial flutter and severe pulmonary arterial hypertension","volume":"149","author":"Showkathali","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1535","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2010.09.065","article-title":"Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension","volume":"146","author":"Ruiz-Cano","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1536","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1540-8167.2012.02387.x","article-title":"Catheter ablation of typical atrial flutter in severe pulmonary hypertension","volume":"23","author":"Bradfield","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1537","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ijcard.2012.06.024","article-title":"Atrial flutter and fibrillation in patients with pulmonary hypertension","volume":"167","author":"Olsson","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1538","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.amjcard.2014.07.079","article-title":"Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension","volume":"114","author":"Wen","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1539","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.amjcard.2015.09.039","article-title":"Supraventricular arrhythmias in patients with pulmonary arterial hypertension","volume":"116","author":"Cannillo","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1540","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018790316","article-title":"Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension","volume":"8","author":"Smith","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2023.08.017_bib1541","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95508-3","article-title":"Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia","volume":"11","author":"Kamada","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2023.08.017_bib1542","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.hrtlng.2021.09.001","article-title":"A\u00a0systematic literature review and meta-analysis on the impact of COPD on atrial fibrillation patient outcome","volume":"51","author":"Ye","year":"2022","journal-title":"Heart Lung"},{"key":"10.1016\/j.jacc.2023.08.017_bib1543","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1055\/s-0036-1598005","article-title":"Pulmonary embolism and atrial fibrillation: two sides of the same coin? A systematic review","volume":"43","author":"Bikdeli","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib1544","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106862","article-title":"Frequency and prognostic significance of atrial fibrillation in acute pulmonary embolism: a pooled analysis","volume":"199","author":"Noubiap","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1545","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2016.08.011","article-title":"Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry","volume":"181","author":"Proietti","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1546","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/thoraxjnl-2016-208412","article-title":"Beta-lockers, heart disease and COPD: current controversies and uncertainties","volume":"72","author":"Baker","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jacc.2023.08.017_bib1547","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/687767","article-title":"Assessment of the physiologic contribution of right atrial function to total right heart function in patients with and without pulmonary arterial hypertension","volume":"6","author":"Sivak","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jacc.2023.08.017_bib1548","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1080\/14656566.2019.1621290","article-title":"Pharmacotherapeutic strategies for atrial fibrillation in pregnancy","volume":"20","author":"Georgiopoulos","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jacc.2023.08.017_bib1549","first-page":"120","article-title":"Arrhythmias\u00a0in pregnancy","volume":"8","author":"Tamirisa","year":"2022","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1550","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.115.015242","article-title":"Pregnancy in women with a mechanical heart valve: data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC)","volume":"132","author":"van Hagen","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1551","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/CIRCULATIONAHA.116.026681","article-title":"Burden of arrhythmia in pregnancy","volume":"135","author":"Vaidya","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1552","first-page":"284","article-title":"Atrial fibrillation or flutter during pregnancy in patients with structural heart disease: data from the ROPAC (Registry on Pregnancy and Cardiac Disease)","volume":"1","author":"Salam","year":"2015","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1553","article-title":"Atrial fibrillation and atrial flutter in pregnant women-a population-based study","volume":"5","author":"Lee","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1554","article-title":"Impact of a history of hypertension in pregnancy on later diagnosis of atrial fibrillation","volume":"7","author":"Scantlebury","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1555","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.gtc.2016.02.005","article-title":"Gastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea","volume":"45","author":"Body","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jacc.2023.08.017_bib1556","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1557","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review","volume":"73","author":"Halpern","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1558","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCEP.114.001517","article-title":"Contemporary management of arrhythmias during pregnancy","volume":"7","author":"Enriquez","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1559","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1560","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/704763","article-title":"Role of digoxin-like immunoreactive substance in the pathogenesis of transient tachypnea of newborn","volume":"2013","author":"Yalaz","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jacc.2023.08.017_bib1561","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1753944716644584","article-title":"New-onset lone atrial fibrillation in pregnancy","volume":"10","author":"Anugu","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2023.08.017_bib1562","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1563","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00392-015-0893-5","article-title":"Pregnancy outcome after exposure to the novel oral anticoagulant rivaroxaban in women at suspected risk for thromboembolic events: a case series from the German Embryotox Pharmacovigilance Centre","volume":"105","author":"Hoeltzenbein","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1564","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1161\/CIR.0000000000001056","article-title":"Cardio-oncology drug interactions: a scientific statement from the American Heart Association","volume":"145","author":"Beavers","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1565","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/annonc\/mdv029","article-title":"Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions","volume":"26","author":"van Leeuwen","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1566","first-page":"145","article-title":"How to diagnose and manage QT prolongation in cancer patients","volume":"3","author":"Kim","year":"2021","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1567","first-page":"88","article-title":"Oncotherapeutic protein kinase inhibitors associated with pro-arrhythmic liability","volume":"3","author":"Ye","year":"2021","journal-title":"J Am Coll Cardiol CardioOnc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1568","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.amjcard.2015.01.540","article-title":"Relation between cancer and atrial fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study)","volume":"115","author":"O'Neal","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1569","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.21.01797","article-title":"Ibrutinib With rituximab in first-line treatment of older patients with mantle cell lymphoma","volume":"40","author":"Jain","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1570","first-page":"58","article-title":"Net benefit of oral anticoagulants in patients with atrial fibrillation and active cancer: a nationwide cohort study","volume":"22","author":"Atterman","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2023.08.017_bib1571","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11239-020-02304-3","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis","volume":"51","author":"Mariani","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jacc.2023.08.017_bib1572","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1186\/s12885-019-6314-9","article-title":"Incidence of atrial fibrillation in different major cancer subtypes: a nationwide population-based 12 year follow up study","volume":"19","author":"Jakobsen","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jacc.2023.08.017_bib1573","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8985273","article-title":"Association of cancer and the risk of developing atrial fibrillation: a systematic review and meta-analysis","volume":"2019","author":"Yuan","year":"2019","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.jacc.2023.08.017_bib1574","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","article-title":"Insights into onco-cardiology: atrial fibrillation in cancer","volume":"63","author":"Farmakis","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1575","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/bjs.11128","article-title":"Meta-analysis of risk factors and complications associated with atrial fibrillation after oesophagectomy","volume":"106","author":"Schizas","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1576","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijcard.2012.08.036","article-title":"Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients","volume":"165","author":"Hu","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1577","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.867002","article-title":"Higher mortality associated with new-onset atrial fibrillation in cancer patients: a systematic review and meta-analysis","volume":"9","author":"Murtaza","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1578","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/eurheartj\/ehab745","article-title":"Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis","volume":"43","author":"Guha","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1579","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/CIRCULATIONAHA.120.049210","article-title":"Ibrutinib-mediated atrial fibrillation attributable to inhibition of C-terminal Src kinase","volume":"142","author":"Xiao","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1580","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211228","article-title":"Ibrutinib increases the risk of hypertension and atrial fibrillation: systematic review and meta-analysis","volume":"14","author":"Caldeira","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib1581","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ehjqcco\/qcx004","article-title":"Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry","volume":"3","author":"Melloni","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jacc.2023.08.017_bib1582","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620936325","article-title":"Drug-drug interactions of 257 antineoplastic and supportive care agents with 7 anticoagulants: a comprehensive review of interactions and mechanisms","volume":"26","author":"Peixoto de Miranda","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jacc.2023.08.017_bib1583","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216239","article-title":"Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy","volume":"14","author":"Higuchi","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2023.08.017_bib1584","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mayocp.2015.09.009","article-title":"Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology","volume":"91","author":"Al-Kindi","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1585","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1586","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1587","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(09)61340-4","article-title":"Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial","volume":"374","author":"Verdecchia","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2023.08.017_bib1588","article-title":"Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial","volume":"4","author":"Rao","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1589","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/icvts\/ivu454","article-title":"Effectiveness of brain natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing non-cardiac thoracic surgery","volume":"20","author":"Toufektzian","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1590","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jtcvs.2019.01.075","article-title":"A\u00a0brain natriuretic peptide-based prediction model for atrial fibrillation after thoracic surgery: development and internal validation","volume":"157","author":"Amar","year":"2019","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jacc.2023.08.017_bib1591","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.20.02401","article-title":"Atrial fibrillation in patients undergoing allogeneic hematopoietic cell transplantation","volume":"39","author":"Chang","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1592","first-page":"690","article-title":"Pretransplant cardiac evaluation using novel technology","volume":"8","author":"Hemu","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jacc.2023.08.017_bib1593","first-page":"1491","article-title":"Ibrutinib-associated atrial fibrillation","volume":"4","author":"Ganatra","year":"2018","journal-title":"J Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2023.08.017_bib1594","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/ajh.26552","article-title":"First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenstr\u00f6m's macroglobulinemia: a systematic review and meta-analysis","volume":"97","author":"Abushukair","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1595","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005443","article-title":"Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies","volume":"10","author":"Buza","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1596","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000000986","article-title":"Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association","volume":"144","author":"Fradley","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1597","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1598","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ahj.2009.06.031","article-title":"Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study","volume":"158","author":"Watanabe","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1599","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.112.123992","article-title":"Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease","volume":"127","author":"Bansal","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2023.08.017_bib1600","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jacc.2019.04.061","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation and history of liver disease","volume":"74","author":"Qamar","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1601","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.31264","article-title":"Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation","volume":"73","author":"Serper","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jacc.2023.08.017_bib1602","doi-asserted-by":"crossref","first-page":"f84","DOI":"10.1093\/ehjcvp\/pvaa015","article-title":"Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study","volume":"7","author":"Proietti","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2023.08.017_bib1603","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijcard.2018.01.097","article-title":"Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants","volume":"264","author":"Pastori","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1604","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.mayocp.2019.08.027","article-title":"Prevalence and impact of nonalcoholic fatty liver disease in atrial fibrillation","volume":"95","author":"Pastori","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1605","article-title":"Liver cirrhosis in patients with atrial fibrillation: would oral anticoagulation have a net clinical benefit for stroke prevention?","volume":"6","author":"Kuo","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1606","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ehjcvp\/pvab032","article-title":"Anticoagulation in atrial fibrillation and liver disease: a pooled-analysis of >20 000 patients","volume":"8","author":"Chen","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2023.08.017_bib1607","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.jacc.2019.04.052","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and liver disease","volume":"73","author":"Lee","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1608","article-title":"Effectiveness and safety of non-vitamin K antagonist oral anticoagulant and warfarin in cirrhotic patients with nonvalvular atrial fibrillation","volume":"8","author":"Lee","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1609","article-title":"Efficacy and safety of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with impaired liver function: a retrospective cohort study","volume":"7","author":"Wang","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2023.08.017_bib1610","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40256-021-00482-w","article-title":"Comparison of the efficacy and safety of direct oral anticoagulants and vitamin k antagonists in patients with atrial fibrillation and concomitant liver cirrhosis: a systematic review and meta-analysis","volume":"22","author":"Lee","year":"2022","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2023.08.017_bib1611","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/bcp.12054","article-title":"Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor","volume":"76","author":"Kubitza","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1612","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13397","article-title":"Direct oral anticoagulants and advanced liver disease: a systematic review and meta-analysis","volume":"51","author":"Menichelli","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacc.2023.08.017_bib1613","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jcph.550","article-title":"An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics","volume":"55","author":"Mendell","year":"2015","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1614","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40268-021-00359-y","article-title":"Apixaban Pharmacokinetics and pharmacodynamics in subjects with mild or moderate hepatic impairment","volume":"21","author":"Frost","year":"2021","journal-title":"Drugs R D"},{"key":"10.1016\/j.jacc.2023.08.017_bib1615","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/0091270010393342","article-title":"Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, with coadministration of digoxin","volume":"52","author":"Stangier","year":"2012","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1616","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ahj.2017.12.007","article-title":"The Optimal Anti-Coagulation for Enhanced-Risk Patients Post-Catheter Ablation for Atrial Fibrillation (OCEAN) trial","volume":"197","author":"Verma","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2023.08.017_bib1617","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00392-015-0933-1","article-title":"Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation","volume":"105","author":"Schrickel","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1618","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/jce.12387","article-title":"Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment","volume":"25","author":"Riley","year":"2014","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2023.08.017_bib1619","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jce.12864","article-title":"Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study","volume":"27","author":"Passman","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2024.05.033","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000}},{"DOI":"10.1016\/j.jacc.2024.01.020","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723064653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109723064653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T08:22:00Z","timestamp":1738916520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109723064653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":1617,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0735109723064653"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2023.08.017","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2023.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}